PMID	Entity1	Entity2	Response
15236594	ER-60	CNX	"Yes, there is an explicit relationship between ""ER-60"" and ""CNX"" as ER-60 facilitates the oxidative folding of glycoproteins via interaction with calnexin (CNX). Additionally, the relationship is further supported by experiments revealing the role of certain domains in ER-60 (such as b and b') for binding with CNX and calreticulin (CRT)."
15236594	ER-60	CRT	"Yes, there is an explicit relationship between ""ER-60"" and ""CRT"" as described in the context. ER-60 is a protein that facilitates the oxidative folding of glycoproteins by interaction with calreticulin (CRT). The relationship lies in their cooperative interaction and function in protein folding."
15236594	CNX	CRT	"Yes, there is an explicit relationship between ""CNX"" and ""CRT"" as well as ER-60 in this context. The text describes that both CNX and CRT interact with ER-60, which is involved in the oxidative folding of glycoproteins, in the endoplasmic reticulum. Furthermore, the relationship between CNX (calnexin) and CRT (calreticulin) is also established through their interaction with the ER-60 molecule in binding and oxidative-refolding processes."
15246187	Cox-2	EGFR	Yes (Cox-2 expression is strongly associated with higher EGFR expression and they show a similar distribution pattern in this context.)
15246187	Cox-2	P53	"Yes, The explicit relationship between ""Cox-2"" and ""P53"" in the provided context is that higher Cox-2 expression is associated with higher P53 expression. No direct relationship between them through EGFR signaling is mentioned in the text. So the answer is ""yes"", there's a relationship but indirectly via the common association with higher EGFR and Ki-67 LI expression."
15246187	Cox-2	Ki-67	"Yes, there is an explicit association described between Cox-2 and Ki-67 as higher Cox-2 expression was strongly associated with a Ki-67 LI above 20%. Additionally, Cox-2 expression showed a significant difference in survival towards worse prognosis which might be associated with tumor progression."
15246187	EGFR	P53	"Yes (There is a relationship mentioned between Cox-2, EGFR, and P53 where higher Cox-2 expression is strongly associated with higher EGFR and P53 expression.)"
15246187	EGFR	Ki-67	"Yes, there is an association between Cox-2 (which is related to EGFR signaling) and Ki-67 expression mentioned in the text. Higher Cox-2 expression was strongly associated with higher EGFR and P53 expression as well as a Ki-67 LI above 20%."
15246187	P53	Ki-67	"No, in this context, there is an explicit relationship between ""P53"" and ""Ki-67"" as well as ""Cox-2"" and ""Ki-67"" since higher expression of these markers is associated with a Ki-67 index above 20% (P < 0.01). There is no explicitly described relationship between ""P53"" and ""Ki-67"" and ""Cox-2"" and ""Ki-67"" mentioned in relation to each other. However, there is a noted strong association between higher expression of ""Cox-2"" and higher expressions of ""EGFR"" and ""P53"". Therefore, while no direct relationship is specified between ""P53"" and ""Ki-67"" or ""Cox-2"" and ""Ki-67"" due to their only common linkage through ""Cox-2"" expression, the provided context does highlight relationships involving all these markers. To answer the original question, a cautious but accurate response is ""no"" for a direct explicit relationship between ""P53"" and ""Ki-67"" or ""Cox-2"" and ""Ki-67"", but there is an indirect relationship between all the mentioned markers."
15248066	AQP1	AQP3	"Yes, there is an explicit relationship between AQP1 and AQP3 in this context, as both are examined for their mRNA and protein expression and their roles in water movement in pulmonary oedema. AQP1 is different from AQP3 in terms of their expression locations (endothelia versus large airways and bronchioles, respectively) and the effects of thiourea treatment on their mRNA levels (AQP3 increased while AQP1 decreased)."
15248066	AQP1	AQP4	"Yes, there is an explicit relationship between ""AQP1"" and ""AQP4"" mentioned in the context as they are both expressed in the rat lung and have distinct locations, with AQP1 present in endothelia and AQP4 in the basolateral membrane of airway cells."
15248066	AQP1	AQP5	"No, there is no explicit relationship described between AQP1 and AQP5 in this context. Both proteins are mentioned to be expressed in different cell types, but no direct relationship between them is indicated."
15248066	AQP1	ENaC	"No, the provided context does not explicitly establish a relationship between AQP1 and ENaC. It only mentions changes in their respective mRNA expression patterns over time."
15248066	AQP1	CFTR	"No, the explicit relationship between ""AQP1"" and ""CFTR"" is that the expression of both mRNAs decreased significantly some time after the peak in lung water content, but there is no direct link between them described in this context."
15248066	AQP3	AQP4	"Yes, there is an indirect relationship between AQP3 and AQP4 mentioned in the context as they both are aquaporins involved in water movement, albeit AQP3 is mainly found in basal cells of large airways and bronchioles, while AQP4 resides in basolateral membrane of airway cells. However, their explicit dynamic relationship during pulmonary oedema could be inferred due to the change in mRNA expression in the thiourea-treated rats."
15248066	AQP3	AQP5	"No, based on the given context, there is no explicit direct relationship between AQP3 and AQP5 described. Both are mentioned as elements potentially involved in water movement but express in different locations and do not share a clear dynamic or interaction relationship."
15248066	AQP3	ENaC	"No, the provided context does not give an explicit direct relationship between AQP3 and ENaC. Although it mentions that the expression of ENaC mRNA decreased after the peak in lung water content, this does not establish an explicit connection between AQP3 and ENaC beyond both being affected by thiourea treatment in rats."
15248066	AQP3	CFTR	"No, there is no explicit direct relationship between ""AQP3"" and ""CFTR"" described in this context. Both are mentioned as mRNA expressions that decrease in response to pulmonary edema, but no specific connection between them is given."
15248066	AQP4	AQP5	"No, there is no explicit relationship described between ""AQP4"" and ""AQP5"" in this context."
15248066	AQP4	ENaC	"No, there is no explicit relationship between ""AQP4"" and ""ENaC"" described in the given context."
15248066	AQP4	CFTR	"No, there isn't an explicit direct relationship between ""AQP4"" and ""CFTR"" described in this context, as they are mentioned separately regarding their changes in mRNA expression in response to thiourea treatment."
15248066	AQP5	ENaC	"No, there is no explicit relationship described between ""AQP5"" and ""ENaC"" in this context."
15248066	AQP5	CFTR	"No, there is no explicit direct relationship between ""AQP5"" and ""CFTR"" described in the given context. The explicit relationships mentioned are between ""AQP3"" and ""thiourea group"" as well as ""AQP3"" being expressed in the bronchioles. Relationships between ""AQP1"", ""AQP3"", ""AQP4"", and ""AQP5"" show dynamics changes during pulmonary oedema. However, ""CFTR"" only appears in the context as a gene whose mRNA expression changes along with ""AQP1"", ""AQP4"", and ""AQP5."""
15248066	ENaC	CFTR	"Yes, there is an indirect relationship suggested between ""ENaC"" and ""CFTR"" as the expression of both decreased significantly some time after the peak in lung water content. However, there is no explicit direct relationship mentioned between ENaC and CFTR. Similarly, while AQP3 is related to water movement and its expression affects other AQPs and sodium channels (including ENaC and CFTR), an explicit direct relationship between AQP3 and CFTR or ENaC is not discussed."
15248214	rsCD154	TNFalpha	"Yes, there is an explicit relationship between ""rsCD154"" and ""TNFalpha"" as stimulation of CD14+ synovial cells by recombinant soluble CD154 (rsCD154) significantly induced expression of tumor necrosis factor alpha (TNFalpha). Additionally, the CD40 CD154 interaction correlates to the production of TNFalpha through activation of specific pathways in CD14+ synovial cells from RA patients."
15248214	rsCD154	IL-1alpha	"Yes, there is an explicit relationship between ""rsCD154"" and ""IL-1alpha"" as stimulation of CD14+ synovial cells from RA patients by recombinant soluble CD154 (rsCD154) significantly induced expression of interleukin-1alpha (IL-1alpha)."
15248214	rsCD154	IL-1beta	"Yes, there is an explicit relationship between ""rsCD154"" and ""IL-1beta"" as stimulation of CD14+ synovial cells from RA patients by recombinant soluble CD154 (rsCD154) significantly induced expression of interleukin-1beta (IL-1beta). This relationship is further established as the CD40 CD154 interaction in CD14+ synovial cells from RA patients results in the production of IL-1beta, which amplifies inflammatory responses."
15248214	rsCD154	IFNgamma	"Yes (The relationship is explicitly described as rsCD154 interacting with IFNgamma to produce higher levels of cytokines IL-6, IL-8, and monocyte chemoattractant protein 1, which ultimately amplifies inflammatory responses.)"
15248214	rsCD154	IL-6	"Yes, there is an explicit relationship between ""rsCD154"" and ""IL-6"" in the given context, as stimulation of CD14+ synovial cells from RA patients by rsCD154 significantly induced production of IL-6 along with other cytokines and chemokines."
15248214	rsCD154	IL-8	"Yes, in this context, rsCD154 (recombinant soluble CD154) leads to the induction of various cytokines and chemokines such as TNFα, IL-1α, and IL-1β in CD14+ synovial cells from RA patients. While rsCD154 does not explicitly mentioned to directly influence IL-8 production, it stimulates cells to produce TNFα, IL-1α, and IL-1β, which in turn amplify inflammatory responses by stimulating FLS and produce IL-8 along with IL-6 and monocyte chemoattractant protein 1. Therefore, although the explicit relationship is not direct, there is an indirect relationship between ""rsCD154"" and ""IL-8"" through the signaling pathway and production of inflammatory mediators."
15248214	rsCD154	monocyte chemoattractant protein 1	"Yes, there is an explicit relationship between ""rsCD154"" and ""monocyte chemoattractant protein 1"" as stimulation of CD14+ synovial cells from RA patients by recombinant soluble CD154 (rsCD154) significantly induced the production of monocyte chemoattractant protein 1 by fibroblast-like synoviocytes (FLS)."
15248214	rsCD154	ERK-1	Yes (The text explains that stimulation with rsCD154 activates the ERK-1 and ERK-2 pathways in CD14+ synovial cells from RA patients.)
15248214	rsCD154	ERK-2	"Yes, in the given context, there is an explicit relationship between ""rsCD154"" and ""ERK-2"" as stimulation with rsCD154 plus IFNγ induces the activation of ERK-1, ERK-2, p38 MAPK, and NF-κB."
15248214	rsCD154	p38 MAPK	"Yes (The context provided explicitly shows a relationship between rsCD154 and p38 MAPK, as rsCD154 plus IFNγ stimulation activates p38 MAPK, and specific inhibitors of p38 MAPK reduce cytokine production in CD14+ synovial cells from RA patients.)"
15248214	rsCD154	NF-kappaB	"Yes, in the given context, there is an explicit relationship between ""rsCD154"" and ""NF-kappaB"" as stimulation with rsCD154 plus IFNgamma induces the activation of NF-kappaB."
15248214	rsCD154	CD40	"Yes, there is an explicit relationship between ""rsCD154"" (recombinant soluble CD154) and ""CD40"" in this context. The interaction between CD40 and CD154 (through stimulation with rsCD154) activates MAPK ERK-1, ERK-2, p38, and NF-kappaB pathways in CD14+ synovial cells from rheumatoid arthritis (RA) patients. This leads to production of inflammatory cytokines and chemokines that amplify synovial inflammation in affected joints."
15248214	rsCD154	CD154	"Yes, there is an explicit relationship between ""rsCD154"" and ""CD154"" mentioned in the text. CD14+ synovial cells from rheumatoid arthritis patients are significantly induced to express inflammatory molecules such as TNFα, IL-1α, and IL-1β upon stimulation by recombinant soluble CD154 (rsCD154). The interaction between CD40 and CD154, which includes rsCD154, activates multiple signaling pathways in synovial cells and leads to production of inflammatory mediators."
15248214	TNFalpha	IL-1alpha	"Yes, there is an explicit relationship between ""TNFalpha"" and ""IL-1alpha"" mentioned in the context as both are significantly induced cytokines in CD14+ synovial cells from RA patients stimulated by rsCD154, and they also contribute to amplifying inflammatory responses by stimulating FLS through the CD40 CD154 interaction and its signal transduction pathways."
15248214	TNFalpha	IL-1beta	"Yes, there is an explicit relationship between ""TNFalpha"" and ""IL-1beta"" as they are produced in CD14+ synovial cells from RA patients after CD40 ligation and amplify the inflammatory response by stimulating FLS. Their production is also regulated by specific inhibitors of MAPK ERK-1 ERK-2 kinases and p38 MAPK signaling pathways."
15248214	TNFalpha	IFNgamma	"Yes, there is an indirect relationship between TNFalpha and IFNgamma in the context provided. CD14+ synovial cells from RA patients, stimulated by rsCD154 (recombinant soluble CD154) plus IFNgamma, induced higher production of inflammatory cytokines such as TNFalpha, IL-1alpha, and IL-1beta, which then acted as mediators to increase the production of other cytokines (such as IL-6, IL-8, and monocyte chemoattractant protein 1) by fibroblast-like synoviocytes (FLS). This signaling provides a pathway for the mutual influence between TNFalpha and IFNgamma in amplifying synovial inflammation in patients with rheumatoid arthritis."
15248214	TNFalpha	IL-6	"Yes, there is an explicit relationship between TNFalpha and IL-6 in the given context as CD14+ synovial cells stimulated with certain agents induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS (fibroblast-like synoviocytes) through TNFalpha, IL-1alpha, and IL-1beta mediated pathways."
15248214	TNFalpha	IL-8	"Yes (From the context, it is explicit that CD40 CD154 interaction in CD14+ synovial cells from RA patients produces cytokines TNFalpha, IL-1alpha, and IL-1beta. These cytokines, in turn, amplify inflammatory responses by stimulating FLS, including IL-8 production.)"
15248214	TNFalpha	monocyte chemoattractant protein 1	"Yes, in this context, there is an explicit relationship between TNFalpha and the cytokines and chemokines (such as IL-6, IL-8, and monocyte chemoattractant protein 1) produced through its mediated pathways in response to stimulation of CD14+ synovial cells from rheumatoid arthritis patients by rsCD154 with interferon-gamma (IFNgamma)."
15248214	TNFalpha	ERK-1	"Yes, there is an explicit relationship between ""TNFalpha"" and ""ERK-1"" as the text explains that stimulation with a certain substance induced the activation of ERK-1 and ERK-2 (ERK being the overall term for these kinases), and it also directly mentions that specific inhibitors of MAPK ERK-1 and ERK-2 kinases significantly reduced the production of TNFalpha. This indicates a direct relationship between these two entities in the context of signal transduction and inflammatory responses in rheumatoid arthritis patients."
15248214	TNFalpha	ERK-2	"Yes (This answer is based on the given context, where it is mentioned that stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB, and specific inhibitors of MAPK ERK-1 ERK-2 kinases contributed to reducing the production of certain cytokines.)"
15248214	TNFalpha	p38 MAPK	"Yes (This is because the text mentions that stimulation with certain agents induced activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB pathways in CD14+ synovial cells, thus establishing a relationship between these signaling molecules during the inflammatory response.)"
15248214	TNFalpha	NF-kappaB	"Yes, there is an explicit relationship between ""TNFalpha"" and ""NF-kappaB"" in this context as the activation of MAPK ERK-1, ERK-2, p38 MAPK, and NF-kappaB is involved in the production of TNFalpha by CD14+ synovial cells from RA patients after CD40 ligation."
15248214	TNFalpha	CD40	"Yes (The text provides evidence of a direct relationship between ""TNFalpha"", ""IL-1alpha"", and ""IL-1beta"" production as a result of CD40 ligation, which amplifies synovial inflammation.)"
15248214	TNFalpha	CD154	"Yes, there is an explicit relationship between ""TNFalpha"" and ""CD154"" in this context. Stimulation of CD14+ synovial cells from patients with rheumatoid arthritis by recombinant soluble CD154 (rsCD154) significantly induced the expression of TNFalpha. The CD40 CD154 interaction is involved in producing TNFalpha which, in turn, amplifies inflammatory responses."
15248214	IL-1alpha	IL-1beta	"Yes (Justification: The text explains that the CD40 CD154 interaction in CD14+ synovial cells from RA patients produces cytokines, including TNFalpha, IL-1alpha, and IL-1beta. This indicates an explicit relationship between IL-1alpha and IL-1beta due to their being mentioned together and originating from the same cellular mechanism.)"
15248214	IL-1alpha	IFNgamma	"Yes, IL-1alpha and IFNgamma are explicitly related in this context because CD14+ synovial cells from RA patients stimulated with recombinant soluble CD154 (rsCD154) plus interferon-gamma (IFNgamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by fibroblast-like synoviocytes (FLS) through mediators such as TNFalpha, IL-1alpha, and IL-1beta."
15248214	IL-1alpha	IL-6	"Yes (Based on the given context, there is an explicit relationship between IL-1alpha and IL-6 as they are both produced due to the CD40 CD154 interaction in CD14+ synovial cells from RA patients, leading to the amplification of inflammatory responses in affected joints.)"
15248214	IL-1alpha	IL-8	"Yes, in this context, there is an explicit relationship between ""IL-1alpha"" and ""IL-8"" as both are significantly produced cytokines in CD14+ synovial cells from RA patients when stimulated with rsCD154 plus IFNgamma. This production increases through TNFalpha, IL-1alpha, and IL-1beta-mediated pathways."
15248214	IL-1alpha	monocyte chemoattractant protein 1	"Yes, there is an explicit relationship between ""IL-1alpha"" and ""RA patients' CD14+ synovial cells stimulated by rsCD154 plus interferon-gamma (IFNgamma)"", as this combination induces significantly higher production of IL-1alpha. Additionally, the CD40 CD154 interaction's signaling pathways contribute to the production of IL-1alpha in CD14+ synovial cells. Furthermore, this amplification of inflammatory responses by CD14+ synovial cells through the production of IL-1alpha also involves the induction of monocyte chemoattractant protein 1 in fibroblast-like synoviocytes (FLS)."
15248214	IL-1alpha	ERK-1	"Yes (The text explicitly states that stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1 and ERK-2, and inhibiting MAPK ERK-1 ERK-2 kinases reduced production of TNFalpha and IL-1beta by rsCD154 plus IFNgamma-stimulated CD14+ synovial cells.)"
15248214	IL-1alpha	ERK-2	"Yes, there is an explicit relationship between ""IL-1alpha"" and the activation of ERK-1, ERK-2 kinases, as described in the context, where stimulation with specific agents induces the activation of ERK-1, ERK-2 kinases and leads to the production of IL-1alpha in CD14+ synovial cells from RA patients."
15248214	IL-1alpha	p38 MAPK	"Yes, based on the given context, there is an explicit relationship between ""IL-1alpha"" and the activation of p38 MAPK pathways, as specific inhibitors of p38 MAPK reduced the production of IL-1alpha in CD14+ synovial cells from patients with rheumatoid arthritis."
15248214	IL-1alpha	NF-kappaB	Yes (The context describes that the CD40 CD154 interaction activates the NF-kappaB pathway in CD14+ synovial cells from RA patients to produce IL-1alpha and other cytokines.)
15248214	IL-1alpha	CD40	"Yes (Justification: In this context, activation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis leads to the activation of multiple signal transduction pathways, including ERK-1, ERK-2, p38 MAPK, and NF-kappaB, resulting in the production of TNFalpha, IL-1alpha, and IL-1beta. This indicates a relationship between CD40 and the production of inflammatory responses, which includes IL-1alpha.)"
15248214	IL-1alpha	CD154	"Yes (The relationship between IL-1alpha and CD154 is indirect, as CD40 ligation leads to activation of pathways resulting in the production of TNFalpha, IL-1alpha, and IL-1beta, which in turn amplify inflammatory responses.)"
15248214	IL-1beta	IFNgamma	"Yes, there is an explicit relationship between IL-1beta and the combination of CD14+ synovial cells from rheumatoid arthritis patients being stimulated by soluble CD154 (rsCD154) and interferon-gamma (IFNgamma), as this combination induces IL-1beta production, which then amplifies inflammatory responses by stimulating fibroblast-like synoviocytes (FLS)."
15248214	IL-1beta	IL-6	"Yes, there is an explicit relationship between ""IL-1beta"" and ""IL-6"" mentioned in the context, as induction of IL-1beta through CD40 CD154 stimulation leads to amplification of inflammatory responses by stimulating fibroblast-like synoviocytes (FLS), which then produce IL-6."
15248214	IL-1beta	IL-8	"Yes, based on the given context, there is an explicit relationship between ""IL-1beta"" and the CD40 CD154 interaction through the activation of ERK, p38, and NF-kappaB pathways. IL-1beta is produced in CD14+ synovial cells from patients with rheumatoid arthritis stimulated by the CD40 CD154 interaction, and its production contributes to the amplification of inflammatory responses when stimulating fibroblast-like synoviocytes (FLS)."
15248214	IL-1beta	monocyte chemoattractant protein 1	"Yes, there is an explicit relationship described in this context between ""IL-1beta"" and the amplification of synovial inflammation through CD40 stimulation on CD14+ synovial cells from patients with rheumatoid arthritis. IL-1beta, along with TNFalpha and IL-1alpha, is produced by CD14+ synovial cells that are activated through the ERK, p38, and NF-kappaB pathways by CD40 CD154 interaction. This production of cytokines leads to increased production of IL-6, IL-8, and monocyte chemoattractant protein 1 by fibroblast-like synoviocytes (FLS), further amplifying the inflammatory response."
15248214	IL-1beta	ERK-1	"Yes, there is an explicit relationship between ""IL-1beta"" and the activated ERK-1 MAPK pathway in CD14+ synovial cells from rheumatoid arthritis patients. Stimulation of these cells induces ERK-1 activation, which results in the production of factors such as IL-1beta that subsequently amplify inflammatory responses."
15248214	IL-1beta	ERK-2	"Yes, there is an explicit relationship between ""IL-1beta"" and ""ERK-2"" in this context, as stimulation with rsCD154 plus IFNgamma induced activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB, and specific inhibitors of MAPK ERK-1 ERK-2 kinases reduced production of TNFalpha and IL-1beta."
15248214	IL-1beta	p38 MAPK	"Yes, IL-1beta is explicitly related to the CD40 CD154 interaction and signal transduction pathways in CD14+ synovial cells from rheumatoid arthritis patients, as stimulation induces its expression and its production is influenced by activation of pathways like p38 MAPK and ERK-1/2. TNFalpha, IL-1alpha, and IL-1beta mediated pathways participate in the higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by fibroblast-like synoviocytes."
15248214	IL-1beta	NF-kappaB	"Yes, there is an explicit relationship between ""IL-1beta"" and the signal transduction pathways involving ERK, p38 MAPK, and NF-kappaB described in the context. Activation of these pathways in CD14+ synovial cells from patients with rheumatoid arthritis (RA) contributes to the production of IL-1beta."
15248214	IL-1beta	CD40	"Yes (Based on the text, there is an explicit relationship between IL-1beta and CD40, as stimulation of CD14+ synovial cells in RA patients by soluble CD154 (rsCD154) induces IL-1beta expression, and this pathway is linked to the CD40 CD154 interaction.)"
15248214	IL-1beta	CD154	"Yes, there is an explicit relationship between ""IL-1beta"" and ""CD154"" through the CD40 CD154 interaction in CD14+ synovial cells from patients with rheumatoid arthritis (RA). CD14+ synovial cells stimulated by recombinant soluble CD154 (rsCD154) induce the expression of IL-1beta, which in turn participates in the amplification of synovial inflammation."
15248214	IFNgamma	IL-6	"Yes, based on the provided context, an explicit relationship exists between ""IFNgamma"" and ""IL-6"" as the stimulation of CD14+ synovial cells with recombinant soluble CD154 (rsCD154) plus interferon-gamma (IFNgamma) leads to a significant increase in production of IL-6 by fibroblast-like synoviocytes (FLS)."
15248214	IFNgamma	IL-8	"Yes, in the given context, there is an explicit relationship between ""IFNgamma"" and the production of ""IL-8"" through the interaction between the CD40 CD154 pathway and the activation of MAPK ERK-1, ERK-2, p38, and NF-kappaB in CD14+ synovial cells from patients with rheumatoid arthritis."
15248214	IFNgamma	monocyte chemoattractant protein 1	"Yes, there is an explicit relationship between ""IFNgamma"" and ""monocyte chemoattractant protein 1"" mentioned in the text. CD14+ synovial cells stimulated with rsCD154 (recombinant soluble CD154) plus IFNgamma (interferon-gamma) induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by fibroblast-like synoviocytes (FLS)."
15248214	IFNgamma	ERK-1	"Yes (There is an explicit relationship between ""IFNgamma"" and the described inflammatory cytokine expression, which involves activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB cascades in CD14+ synovial cells from RA patients.)"
15248214	IFNgamma	ERK-2	"Yes, there is an explicit relationship between ""IFNgamma"" and ""ERK-2"" in this context, as stimulation with rsCD154 plus IFNgamma induces the activation of ERK-1 and ERK-2."
15248214	IFNgamma	p38 MAPK	"Yes (The relationship between ""IFNgamma"" and the activation of signal transduction pathways such as ERK-1, ERK-2, p38 MAPK through the CD40 CD154 interaction is directly mentioned in the given context.)"
15248214	IFNgamma	NF-kappaB	"Yes (Based on the provided context, there is an explicit relationship between ""IFNgamma"" and the amplification of inflammatory responses through its involvement in inducing IL-6, IL-8, and monocyte chemoattractant protein 1, as well as the upregulation of MAPK and NF-kappaB activation in CD40 CD154 interactions in CD14+ synovial cells from RA patients.)"
15248214	IFNgamma	CD40	"Yes, there is an explicit relationship between ""IFNgamma"" and ""CD40"" in this context. The co-stimulation with recombinant soluble CD154 (rsCD154) plus interferon-gamma (IFNgamma) significantly increases the production of inflammatory cytokines and chemokines, such as IL-6, IL-8, and monocyte chemoattractant protein 1. This process involves the activation of signaling pathways (ERK-1, ERK-2, p38 MAPK, and NF-kappaB) through CD40 and mediated by TNFalpha, IL-1alpha, and IL-1beta."
15248214	IFNgamma	CD154	"Yes (From the provided context, there is an explicit relationship between ""IFNgamma"" and ""CD154""; when CD14+ synovial cells are stimulated with recombinant soluble CD154 (rsCD154) plus interferon-gamma (IFNgamma), it induces significant higher production of cytokines by FLS through mediated pathways, suggesting that both CD154 and IFNgamma interact to amplify inflammation.)"
15248214	IL-6	IL-8	"No, In the given context, there is a description of a relationship between the activation of CD40 on CD14+ synovial cells and the production of various cytokines and chemokines. CD14+ synovial cells from rheumatoid arthritis (RA) patients, after being stimulated by recombinant soluble CD154 (rsCD154) in the presence of interferon-gamma (IFN-γ), induce the production of IL-6 and IL-8 in fibroblast-like synoviocytes (FLS). This enhanced production of IL-6 and IL-8 is mediated by TNF-α, IL-1α, and IL-1β; both IL-6 and IL-8 are part of the amplification of inflammatory responses in RA."
15248214	IL-6	monocyte chemoattractant protein 1	"Yes, there is an explicit relationship described between ""IL-6"" and the amplification of the synovial inflammatory response as CD14+ synovial cells from patients with rheumatoid arthritis stimulated with rsCD154 plus IFNγ induced higher production of IL-6 in fibroblast-like synoviocytes (FLS) through TNFα, IL-1α, and IL-1β mediated pathways. Similarly, IL-8 and monocyte chemoattractant protein 1 (MCP-1) are also mentioned in the context of this relationship."
15248214	IL-6	ERK-1	"Yes (ERK-1 is explicitly shown to be activated by stimulation with rsCD154 plus IFNgamma, and inhibitors of MAPK ERK-1/ERK-2 kinases reduce production of cytokines in the context of CD14+ synovial cells.)"
15248214	IL-6	ERK-2	"Yes, there is an explicit relationship between ""IL-6"" and the overall synovial inflammatory response described in the context, as it states that CD14+ synovial cells stimulated with rsCD154 plus IFNgamma induced higher production of IL-6, IL-8, and monocyte chemoattractant protein 1. Additionally, there is an explicit relationship between the ""ERK-1/ERK-2"" kinases and the production of inflammatory cytokines TNFalpha and IL-1beta, as the text mentions that stimulation with rsCD154 plus IFNgamma activated ERK-1, ERK-2, p38 MAPK, and NF-kappaB signaling pathways, and specific inhibitors of MAPK ERK-1 ERK-2 kinases reduced the production of TNFalpha and IL-1beta."
15248214	IL-6	p38 MAPK	"Yes (Justification: The text establishes that stimulation with specific factors induces the activation of p38 MAPK alongside other pathways like ERK-1, ERK-2, and NF-kappaB in the context of CD40 CD154 interaction. This relationship between p38 MAPK and the activation due to this specific interaction indirectly involves IL-6 through its role in amplifying the synovial inflammation.)"
15248214	IL-6	NF-kappaB	"Yes, there is an explicit relationship between IL-6 and the overall inflammatory response, as it is mentioned that ""CD14+ RA synovial cells stimulated with rsCD154 plus interferon-gamma (IFNγ) induced significantly higher production of IL-6"" when amplifying inflammatory responses in fibroblast-like synoviocytes (FLS). Furthermore, the study shows that stimulation with rsCD154 plus IFNγ activates various pathways including MAPKs and NF-kappaB, which are involved in the production of cytokines like TNFα, IL-1α, and IL-1β. While IL-6 itself is not directly related to NF-kappaB signaling, the inflammatory response pathways associated with IL-6 are linked to NF-kappaB activation."
15248214	IL-6	CD40	"Yes (The context establishes a relationship between ""IL-6"" and ""CD40"" through the CD40 CD154 interaction, which activates pathways leading to the production of TNFalpha, IL-1alpha, and IL-1beta. These cytokines, in turn, amplify inflammatory responses by stimulating FLS to produce IL-6 and other factors.)"
15248214	IL-6	CD154	"Yes, there is an explicit relationship between ""IL-6"" and the CD40 CD154 interaction, as CD14+ synovial cells stimulated with rsCD154 plus IFNgamma can induce significantly higher production of IL-6 by fibroblast-like synoviocytes (FLS) via mediators such as TNFalpha, IL-1alpha, and IL-1beta. Moreover, the stimulation activates multiple signaling pathways including the ERK, p38, and NF-kappaB pathways, providing a mechanistic link between CD154 and the production of IL-6 and other cytokines involved in inflammation."
15248214	IL-8	monocyte chemoattractant protein 1	"Yes (From the given context, there is an explicit relationship between IL-8 and the overall amplification of synovial inflammation in affected joints. This relationship occurs through the CD40 CD154 interaction, which activates specific signal transduction pathways leading to the production of IL-8 by fibroblast-like synoviocytes (FLS))."
15248214	IL-8	ERK-1	"Yes (The text describes that the CD40 CD154 interaction activates the ERK pathways in CD14+ synovial cells from RA patients, which leads to the production of cytokines such as TNFalpha and IL-1alpha/IL-1beta. These cytokines, along with IL-8, are associated with amplifying inflammatory responses.)"
15248214	IL-8	ERK-2	"Yes, there is an explicit relationship between ""IL-8"" and the overall process of synovial inflammation in RA, as it is induced by CD14+ synovial cells stimulated with rsCD154 plus IFN-gamma, through mechanisms involving TNF-alpha, IL-1alpha, and IL-1beta. This relationship is indirect but part of a defined signaling pathway described in the context provided. It is also worth mentioning that the activation of ERK-1, ERK-2, and p38 MAPK pathways occurs when stimulating these cells with rsCD154 plus IFN-gamma. These MAPK pathways have been shown to be involved in regulating the expression of various proinflammatory cytokines, including IL-8, in other studies."
15248214	IL-8	p38 MAPK	"Yes (In this context, there is an explicit relationship between IL-8 and the amplification of inflammatory responses in RA joints through the activation of kinases after stimulation with rsCD154 plus IFNgamma, which then affects the production of cytokines by FLS. Additionally, CD14+ synovial cell activation of the p38 MAPK pathway is mentioned, which possibly indirectly links it with IL-8 production through the amplification of inflammatory responses through cytokines mentioned above.)"
15248214	IL-8	NF-kappaB	"Yes, in this context, there is an explicit relationship between IL-8 (specifically through its production being induced by rsCD154 plus IFNgamma stimulation on CD14+ synovial cells from RA patients) and the NF-kappaB signaling pathway, as the activation of NF-kappaB is involved in mediating the production of cytokines and chemokines like IL-6, IL-8, and monocyte chemoattractant protein 1."
15248214	IL-8	CD40	"Yes (The context describes that CD40 ligation induces the production of cytokines such as TNF-alpha, IL-1alpha, and IL-1beta in CD14+ synovial cells from RA patients. These cytokines, in turn, amplify inflammatory responses by stimulating fibroblast-like synoviocytes (FLS). Though IL-8 production is also significantly induced through this pathway, the explicit relationship between CD40 and IL-8 is not directly mentioned or shown. However, due to the involvement of CD40 ligation and the connected inflammatory mechanism, there can be considered an indirect relationship between CD40 and IL-8.)"
15248214	IL-8	CD154	"Yes, there is an explicit relationship between ""IL-8"" and the CD40-CD154 signaling pathway described in this context. CD14+ synovial cells from RA patients, when stimulated by rsCD154 plus IFNγ, produced higher levels of IL-8 through mediators such as TNFα, IL-1α, and IL-1β, which were activated by the signaling pathways including ERK-1, ERK-2, p38 MAPK, and NF-κB."
15248214	monocyte chemoattractant protein 1	ERK-1	"Yes, ERK-1 and ERK-2 (mentioned together as ERK-1/ERK-2 kinases) are explicitly described to be involved in the signal transduction pathway activated by CD40 ligation in CD14+ synovial cells from patients with rheumatoid arthritis, leading to the production of cytokines, including TNFalpha, IL-1alpha, and IL-1beta. The ERK-1/ERK-2 pathway is also involved in the initial production of these cytokines when CD14+ synovial cells are stimulated with rsCD154 plus IFNgamma."
15248214	monocyte chemoattractant protein 1	ERK-2	"Yes, there is an explicit relationship between ""monocyte chemoattractant protein 1"" and the context presented, as it states that CD14+ RA synovial cells stimulated by rsCD154 plus interferon-gamma induced significantly higher production of IL-6, IL-8, and monocyte chemoattractant protein 1 by FLS. The relationship between ""monocyte chemoattractant protein 1"" and ERK-2 in this context is established through the activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB pathways by the CD40 CD154 interaction, which results in the production of cytokines that further amplify inflammatory responses."
15248214	monocyte chemoattractant protein 1	p38 MAPK	"Yes, there is an explicit relationship between ""monocyte chemoattractant protein 1"" and the RA synovial cell inflammatory response through the described amplification process involving CD40, CD154, and specific signaling pathways such as ERK-1, ERK-2, p38 MAPK, and NF-kappaB."
15248214	monocyte chemoattractant protein 1	NF-kappaB	"Yes, there is an explicit relationship described between ""monocyte chemoattractant protein 1"" and the inflammatory response, and this inflammatory response is amplified through the activation of MAPKs, including ERK-1, ERK-2, and p38, as well as NF-kappaB pathways, following the CD40 CD154 interaction in CD14+ synovial cells from patients with rheumatoid arthritis."
15248214	monocyte chemoattractant protein 1	CD40	"Yes, the explicit relationship between ""monocyte chemoattractant protein 1"" and the context provided is that the amplified production of IL-6, IL-8, and monocyte chemoattractant protein 1 by fibroblast-like synoviocytes (FLS) is stimulated by CD14+ synovial cells from rheumatoid arthritis (RA) patients, triggered by recombinant soluble CD154 (rsCD154) in combination with interferon-gamma (IFNγ). This occurs through the mediated pathways of tumor necrosis factor alpha (TNFα), interleukin-1alpha (IL-1α), and interleukin-1beta (IL-1β), which are induced by the CD40 CD154 interaction."
15248214	monocyte chemoattractant protein 1	CD154	"Yes, there is an explicit relationship between ""monocyte chemoattractant protein 1"" and ""CD154"" in this context. CD14+ synovial cells from rheumatoid arthritis patients were stimulated by recombinant soluble CD154 (rsCD154), leading to the significant induction of inflammatory cytokines and chemokines, including monocyte chemoattractant protein 1, through a signaling pathway initiated by CD40 ligation on CD14+ synovial cells from patients with rheumatoid arthritis."
15248214	ERK-1	ERK-2	"Yes, there is an explicit relationship between ERK-1 and ERK-2 described in the text. Both are mentioned as being activated by the CD40 CD154 interaction and as components of the MAPK pathway, with specific inhibitors targeting them providing significant reductions in cytokine production."
15248214	ERK-1	p38 MAPK	"Yes, in this context, there is a direct relationship between ""ERK-1"" and ""ERK-2"" as both are mentioned together in the activation process of signaling pathways. Additionally, there is also a relationship between ""p38 MAPK"" and the production of inflammatory cytokines, TNFalpha, and IL-1beta, since specific inhibitors affecting it have a considerable effect on these cytokines' production."
15248214	ERK-1	NF-kappaB	"Yes, there is an explicit relationship between ""ERK-1"" and the context provided, as it is mentioned that stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1 along with other related pathways. Additionally, inhibitors specific for MAPK ERK-1/ERK-2 kinases reduced cytokine production in CD14+ synovial cells, linking ERK-1 to the studied inflammation mechanisms."
15248214	ERK-1	CD40	"Yes, there is an explicit relationship between ""ERK-1"" and the context given, as it is mentioned that CD40 stimulation activates ERK-1 pathways in CD14+ synovial cells from RA patients to produce cytokines, subsequently amplifying the inflammatory responses."
15248214	ERK-1	CD154	"Yes, in this context, there is an explicit relationship between ""ERK-1"" and ""CD14+ synovial cells"" as ERK-1 activation occurs in response to the CD40 CD154 interaction stimulating CD14+ synovial cells from RA patients. This relationship is also relevant to ERK-1's role in producing TNFalpha, IL-1alpha, and IL-1beta in the amplification of synovial inflammation in affected joints."
15248214	ERK-2	p38 MAPK	"Yes (The explicit relationship between ERK-2 and p38 MAPK is indicated when it states that stimulation with rsCD154 plus IFNgamma induced the activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB.)"
15248214	ERK-2	NF-kappaB	"Yes (The context explicitly describes that the CD40 CD154 interaction activates the ERK, p38, and NF-kappaB pathways, and these pathways result in production of cytokines that amplify inflammation.)"
15248214	ERK-2	CD40	"Yes, there is an explicit relationship between ""ERK-2"" and the context given, as it is mentioned that the activation of ERK-1, ERK-2, p38 MAPK, and NF-kappaB occurs due to stimulation of CD14+ synovial cells from rheumatoid arthritis patients by recombinant soluble CD154 (rsCD154) plus interferon-gamma (IFNgamma). These activated pathways contribute to the production of cytokines such as TNFalpha, IL-1alpha, and IL-1beta, which further amplify inflammatory responses. Furthermore, specific inhibitors of MAPK ERK-1 ERK-2 kinases were shown to reduce the production of these cytokines. However, it is important to note that there is no explicit relationship mentioned in the text between ""ERK-2"" and ""CD40"" directly, but their relationship is mediated through the CD40 CD154 interaction."
15248214	ERK-2	CD154	"Yes, there is an explicit relationship between ""ERK-2"" and the context provided, as the activation of ERK-1 and ERK-2 is linked to the signal transduction pathways induced by CD40 ligation and CD154 stimulation in CD14+ synovial cells from patients with rheumatoid arthritis. This relationship contributes to the production of inflammatory cytokines like TNFalpha, IL-1alpha, and IL-1beta, which further amplify inflammatory responses."
15248214	p38 MAPK	NF-kappaB	"Yes (The explicit relationship between ""p38 MAPK"" and the context is that stimulation with rsCD154 plus IFNgamma activated both the ERK and p38 MAPK pathways. Inhibition of the p38 MAPK pathway reduced the production of inflammatory cytokines by CD14+ synovial cells from patients with rheumatoid arthritis.)"
15248214	p38 MAPK	CD40	"Yes, there is an explicit relationship between ""p38 MAPK"" and ""CD40"" in this context, as activation of the CD40 CD154 interaction leads to the activation of the ERK, p38, and NF-kappaB pathways, which then results in the production of inflammatory cytokines in CD14+ synovial cells in patients with rheumatoid arthritis."
15248214	p38 MAPK	CD154	"Yes, there is an explicit relationship between ""p38 MAPK"" and ""CD154"" as the context describes that the CD40 CD154 interaction activates the ERK, p38, and NF-kappaB pathways, and specifically inhibiting the p38 MAPK signaling pathway reduces the production of key cytokines associated with rheumatoid arthritis."
15248214	NF-kappaB	CD40	"Yes, there is an explicit relationship between ""NF-kappaB"" and ""CD40"" as mentioned in the context that the CD40 CD154 interaction activates the ERK, p38, and NF-kappaB pathways in CD14+ synovial cells from RA patients."
15248214	NF-kappaB	CD154	"Yes, there is an explicit relationship between ""NF-kappaB"" and ""CD154"" as the text mentions that the CD40 CD154 interaction activates the ERK, p38, and NF-kappaB pathways in CD14+ synovial cells from RA patients."
15248214	CD40	CD154	"Yes, there is an explicit relationship between ""CD40"" and ""CD154"" as described in this context. The CD40 CD154 interaction activates certain pathways (ERK, p38, and NF-kappaB) in CD14+ synovial cells from rheumatoid arthritis patients, leading to production of inflammatory cytokines and amplifying inflammation in affected joints."
15251861	HO-1	AT1	"Yes (The relationship described in the context is that ANG II (Angiotensin II) stimulates CO production and release in isolated, perfused rat kidneys, and this action is linked to AT1 receptors activation and involves PKC activation and upregulation of renal HO-1 [heme oxygenase-1] expression.)"
15251861	HO-1	PKC	"Yes, there is an explicit relationship between ""HO-1"" and ""PKC"" as the study shows that the action of ANG II (angiotensin II), involving PKC activation, is linked to upregulation of renal HO-1 but not HO-2 protein expression."
15251861	HO-1	HO-2	"Yes, there is an explicit relationship described between ""HO-1"" and ""ANG II"" as ANG II upregulates renal HO-1 expression and activates AT1 receptors in stimulating CO production and release in isolated, perfused rat kidneys. However, there's no explicit mentioned relationship between ""HO-2"" and ""ANG II"" in this provided context."
15251861	AT1	PKC	"Yes, there is an explicit relationship between ""AT1"" and ""PKC"" in this context. It states that the action of ANG II, which includes stimulating CO production and release in isolated, perfused rat kidneys, ""is linked to the activation of AT1 receptors and involves PKC activation."""
15251861	AT1	HO-2	"Yes, there is an explicit relationship between ""AT1"" (Angiotensin II receptor type 1) and ""HO-2"" in this context. ANG II (Angiotensin II), which binds with AT1, activates PKC (protein kinase C) and it is involved in upregulation of renal HO-1 (heme oxygenase-1) but not HO-2 protein expression. This suggests that ANG II and its receptor AT1 play a role in regulating HO-1 and possibly indirectly affecting HO-2 as well."
15251861	PKC	HO-2	"Yes (The text describes a relationship between PKC and ANG II, and also between ANG II and HO-1, where ANG II involves PKC activation and upregulation of renal HO-1.)"
15258137	Hsp90	Cdc37	"Yes (Hsp90 cooperates with its co-chaperone Cdc37 to support multiple protein kinases, and specific features of protein kinases were identified to interact with both Hsp90 and Cdc37)"
15258137	Hsp90	Lck	"Yes (Lck is used as an example protein kinase in this context, and it is described to interact with both Hsp90 and its co-chaperone Cdc37 in forming high-affinity complexes.)"
15258137	Cdc37	Lck	"Yes (Lck interacts with Cdc37, mainly via the alpha-C-helix and part of its adjoining loop connection to the beta4-strand from the N-terminal lobe of Lck)"
15258196	PLTP	HDL	"Yes, there is an explicit relationship between ""PLTP"" and ""HDL"" as PLTP deficiency affects the anti-inflammatory properties and composition of HDL, resulting in overall improved functioning and reduced ability of LDL to induce monocyte chemotactic activity."
15258196	PLTP	LDL	"Yes, there is an explicit relationship between ""PLTP"" and ""LDL"" described in this context, as PLTP deficiency impacts both the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity."
15258196	HDL	LDL	"Yes, there is an explicit relationship between ""HDL"" and ""LDL"" described in the given context, as PLTP deficiency influences the properties of HDL, its ability to prevent LDL-induced monocyte chemotactic activity, and the impact of HDL on the inflammatory properties of LDL."
15263796	Cyclin D1	Cyclin E	"Yes, in this context, there is an explicit correlation mentioned between cyclin D1 and cyclin E, which is described as ""cyclin D1 expression was positively correlated with p21(Waf1/Cip1) and p27(Kip1) and inversely with the Ki-67 score"", and also ""cyclin E expression was positively related to cyclin E and the two associated proliferating indices Ki-67 and PCNA, as well as with p53 and p27(Kip1) proteins expression."" This means that the expression levels of cyclin D1 and the regulators p21 and p27 are related, while cyclin E expression is associated with proliferating indices and also tied to p27 protein expression."
15263796	Cyclin D1	p21	"Yes, in this context, there is an explicit relationship between ""Cyclin D1"" and ""p21(Waf1/Cip1)"" as it is mentioned that their expressions were positively correlated with each other."
15263796	Cyclin D1	p27	"Yes, there is an explicit positive correlation between cyclin D1 and p21 (Waf1/Cip1) as well as p27 (Kip1) in the given context."
15263796	Cyclin D1	pRb	"Yes, there is an explicit relationship described between Cyclin D1 and pRb in this context, as a positive relationship between the expression of Cyclin D1 and pRb is observed."
15263796	Cyclin D1	p53	"Yes, the text describes explicit relationships between cyclin D1 and p21(Waf1/Cip1), p27(Kip1), and Ki-67, as well as inversely with p53 (through its correlation with p27(Kip1) expression)."
15263796	Cyclin D1	Ki-67	"Yes, an explicit relationship is described between Cyclin D1 and Ki-67 in the given context. Cyclin D1 expression is inversely correlated with the Ki-67 score."
15263796	Cyclin D1	PCNA	"Yes, in the given context, there is an explicit relationship between cyclin E and the proliferating indices Ki-67 and PCNA, as well as between p27(Kip1) and cyclin E expression. Additionally, a positive relationship between p27(Kip1) expression and cyclin D1 expression is also mentioned."
15263796	Cyclin E	p21	"Yes, the explicit relationship stated between ""Cyclin E"" and ""p21"" is a positive relationship, as mentioned in the context where it states, ""a positive relationship between cyclin E expression and ... p27(Kip1) proteins expression was noted,"" and also, ""as well as with p27(Kip1) proteins expression."" Although not directly between Cyclin E and p21, this association to a related molecule implies some degree of correlation in the system."
15263796	Cyclin E	p27	"Yes, there is an explicit positive correlation mentioned between cyclin E expression and the expression of p27(Kip1) protein in the text."
15263796	Cyclin E	pRb	"Yes, there is an explicit relationship between Cyclin E and p53, p27(Kip1), and pRb described in the text. Cyclin E expression correlates with p53 and p27(Kip1) proteins expression and also has a positive relationship with pRb expression."
15263796	Cyclin E	p53	"Yes, there is an explicit relationship mentioned between cyclin E and p53 in this context. It states that positivity of cyclin E immunoreactivity was correlated with the proliferation-associated indices Ki-67 and PCNA, as well as with p53 protein expression."
15263796	Cyclin E	Ki-67	"Yes, the given context explicitly describes a correlation between cyclin E expression and the proliferation-associated index Ki-67. This is mentioned in the statement, ""A positive relationship between cyclin E expression and the two associated proliferating indices Ki-67 and PCNA, as well as with p53 and p27(Kip1) proteins expression was noted."""
15263796	Cyclin E	PCNA	"Yes, in this context, there is an explicit correlation mentioned between cyclin E and PCNA, where a positive relationship between cyclin E expression and the proliferating indices Ki-67 and PCNA was noted."
15263796	p21	p27	"Yes, in this context, there are explicit relationships between ""p21"" and ""p27"" as well as between each protein and various other cell cycle-related proteins. The expression of p21(Waf1/Cip1) and p27(Kip1) was found to be positively related to each other, as well as to cyclins D1 and E, and to some other regulatory proteins. These relationships suggest multiple interconnected pathways in bladder carcinogenesis (growth and regulation of cells in the bladder lining). Therefore, the answer is ""yes""."
15263796	p21	pRb	"Yes, the provided context explicitly describes relationships between p21(Waf1/Cip1) and several proteins including cyclin D1, cyclin E, p27(Kip1), and pRb. It mentions there is a positive relationship between p21(Waf1/Cip1) and cyclin D1, cyclin E, p27(Kip1), and pRb expression."
15263796	p21	p53	"Yes, the text explicitly describes an interrelationship between p21(Waf1/Cip1) and cyclin D1, p27(Kip1), as well as a positive correlation between p21(Waf1/Cip1) expression and p53 protein expression. However, there isn't a direct explicit relationship described between p21 and p53 aside from their correlation."
15263796	p21	Ki-67	"Yes, there is an explicit relationship described between p21 and cyclin D1 in the given context, as it states, ""Cyclin D1 expression was correlated with p21(Waf1/Cip1) and p27(Kip1)"" and the relationship between Ki-67 and cyclin D1 is also noted as ""Cyclin D1 expression was inversely with the Ki-67 score."" However, no direct explicit relationship between Ki-67 and p21 is mentioned in the text."
15263796	p21	PCNA	"Yes, there is an explicit relationship described between ""p21"" and ""PCNA"" in the provided context. The relationship is noted as a positive correlation between ""p21 (Waf1/Cip1)"" expression and the proliferating indices Ki-67 and PCNA."
15263796	p27	pRb	"Yes, there is an explicit relationship mentioned between p27 and pRb in this context, as a positive relationship between p27(Kip1) expression and p21(Waf1/Cip1) and pRb expression is observed."
15263796	p27	p53	"Yes, In this context, there are explicit relationships between ""p27"" and several proteins mentioned in the text, including ""p21(Waf1/Cip1)"" (positively correlated with cyclin D1 and cyclin E), ""p53"" (positively correlated with cyclin E), and ""pRb"" (positively related to p21(Waf1/Cip1) expression). Hence, we can conclude that there is an explicit relationship between p27 and p53 in this provided context. Answer: yes."
15263796	p27	Ki-67	"Yes, there is an explicit correlation between p27(Kip1) and cyclin D1, as well as a positive relationship between p27(Kip1) and cyclins D1, E, p21(Waf1/Cip1), and pRb expression mentioned in the given context. Furthermore, the expression of p27(Kip1) was also inversely correlated with the Ki-67 score."
15263796	p27	PCNA	"Yes, there is an explicit relationship described between p27 and p21(Waf1/Cip1) as well as cyclin D1, and cyclin E. Also, a negative correlation between p27 and the Ki-67 score is mentioned."
15263796	pRb	p53	"No, To answer this question, let's examine the provided text for any direct relationship mentioned between ""pRb"" and ""p53."" In the text, it states that ""A positive relationship between cyclin E expression and the two associated proliferating indices Ki-67 and PCNA, as well as with p53 and p27(Kip1) proteins expression was noted."" However, there is no explicit relationship mentioned between pRb and p53. Answer: No"
15263796	pRb	Ki-67	"Yes, in this given context, there is an explicit correlation mentioned between cyclin D1 expression and the Ki-67 score, where their expressions are inversely related. This indicates that as cyclin D1 expression increases, Ki-67 score decreases and vice versa. Hence, a relationship between ""pRb"" and ""Ki-67"" is not explicitly mentioned."
15263796	pRb	PCNA	"No, to answer this question, we need to analyze the text to identify the relationships between pRb and PCNA. The text discusses the correlation of expression patterns of various molecules, cell-cycle-related proteins, and their significance in urothelial carcinoma. In this context, pRb's correlation is mentioned with the expression of p21(Waf1/Cip1), while PCNA's correlation is mentioned with cyclin E, Ki-67, and p53. However, the text does not provide any explicit association or relationship between pRb and PCNA. Therefore, the response is: no."
15263796	p53	Ki-67	"Yes, there is an explicit correlation described between cyclin E expression and Ki-67 and PCNA in the given context. This indicates that they are related, at least in terms of their positive relationship with each other. Similarly, Ki-67 is inversely correlated with cyclin D1 expression, further establishing relationships between Ki-67 and some proteins mentioned."
15263796	p53	PCNA	"No, the given context describes the correlation between p53 and some cell-cycle-related proteins like Ki-67 and PCNA; it also mentions a positive relationship between cyclin E expression and p53. However, it does not explicitly provide information about the relationship between p53 and p21, p27, cyclins D1, and E, and the other proteins like pRb. As a result, we can't conclude a definite explicit relationship between ""p53"" and ""PCNA"" in the provided context. Nonetheless, ""yes"" for the connection between p53 and Ki-67, and ""yes"" for the association between p53 and cyclin E."
15263796	Ki-67	PCNA	"Yes In the given context, there are correlations mentioned between the expression patterns of Ki-67 and PCNA with cyclin E, as both demonstrated a positive relationship with cyclin E expression. Moreover, Ki-67 is also negatively correlated with cyclin D1 expression. These relationships explicitly mentioned in the text establish the connection between Ki-67 and PCNA and the proteins under study."
15297375	PDGF	Sp1	"Yes, there is an explicit relationship between ""PDGF"" and ""Sp1"" described in the context, as Sp1 and Ets-1 cooperatively activate PDGF transcription in vascular smooth muscle cells (SMCs)."
15297375	PDGF	Sp3	Yes
15297375	PDGF	Egr-1	"Yes, there is an explicit relationship between ""PDGF"" and ""Egr-1"" as mentioned in the text since PDGF expression is under the positive regulatory influence of Sp1, Sp3, and Egr-1. Additionally, there's another explicit relationship mentioned between ""PDGF"" and ""Ets-1"". Ets-1 induces PDGF expression in primary rat aortic SMCs at the level of transcription and mRNA expression, and the PDGF promoter contains a functional cis-acting element for Ets-1. Ets-1 and Sp1 also cooperatively activate PDGF transcription in vascular SMCs."
15297375	PDGF	GCF2	"Yes, there is an explicit relationship between ""PDGF"" and ""Ets-1"" as Ets-1 induces PDGF expression in primary rat aortic SMCs at the level of transcription and mRNA expression and cooperatively activates the PDGF promoter with Sp1. However, the direct relationship between ""PDGF"" and ""GCF2"" mentioned in the context is that PDGF expression is negatively controlled by GCF2."
15297375	PDGF	NF-1	"Yes, in this context, there is an explicit relationship between ""PDGF"" and several transcription factors including Sp1, GCF2, NF-1, and WT-1. While PDGF expression is negatively controlled by NF-1, the text focuses mainly on the interactions between PDGF and other factors such as Ets-1 and Sp1. Therefore, the explicit relationship between NF-1 and PDGF is restricted to NF-1's negative regulatory role."
15297375	PDGF	WT-1	"Yes, there is an explicit relationship between ""PDGF"" and ""WT-1"" in this context, as it is mentioned that PDGF expression is negatively controlled by GCF2, NF-1, and WT-1. Additionally, the relationship between ""PDGF"" and ""Ets-1"" is further described, showcasing Ets-1's positive impact on PDGF expression through direct binding to the PDGF promoter and cooperative interactions with Sp1."
15297375	PDGF	Ets-1	"Yes, there is an explicit relationship between PDGF and Ets-1, as Ets-1 stimulates PDGF gene transcription and induces PDGF expression at the transcriptional level, and this relationship is regulated cooperatively with Sp1."
15297375	Sp1	Sp3	"Yes (The explicit relationship between Sp1 and Sp3 mentioned in the text is that they both have a positive regulatory influence on PDGF expression, along with Egr-1.)"
15297375	Sp1	Egr-1	Yes (Sp1 and Ets-1 have a cooperative relationship in activating PDGF transcription.)
15297375	Sp1	GCF2	"Yes (From the given text, there is an explicit relationship between Sp1 and Ets-1 as they cooperatively activate PDGF transcription in vascular SMCs. However, there is no explicit relationship described between GCF2 and Sp1 in this context.)"
15297375	Sp1	NF-1	"Yes, there is an explicit relationship between ""Sp1"" and ""NF-1"" as both are mentioned as having regulatory effects on PDGF transcription, with Sp1 being under the positive regulatory influence and NF-1 being among the factors that negatively control PDGF expression."
15297375	Sp1	WT-1	"Yes, there is an explicit relationship between ""Sp1"" and ""WT-1"" mentioned in the text as both positively and negatively regulate PDGF transcription. Additionally, there's a direct relationship between ""Sp1"" and ""Ets-1"" as they cooperatively activate PDGF transcription in vascular SMCs. However, there's no direct relationship between ""Sp1"" and ""WT-1"" described in this context."
15297375	Sp1	Ets-1	"Yes, there is an explicit relationship between ""Sp1"" and ""Ets-1"" described in this context as they cooperatively activate PDGF transcription in vascular smooth muscle cells."
15297375	Sp3	Egr-1	"Yes (Ets-1 and Sp1 have a cooperative relationship in activating PDGF transcription in vascular smooth muscle cells, as described in the text.)"
15297375	Sp3	GCF2	"Yes (There is an explicit relationship between Sp3 and Sp1 mentioned in the text as both positively regulating PDGF expression. Sp1 also cooperatively activates PDGF transcription with Ets-1, although GCF2 is mentioned as negatively controlling PDGF expression.)"
15297375	Sp3	NF-1	"No, NF-1 is not directly related to Sp3 in this context provided. Both are mentioned as binders or regulators of the PDGF gene transcription separately, but there's no explicit mention of an interaction between the two."
15297375	Sp3	WT-1	"Yes, there is an explicit relationship between ""Sp3"" and ""WT-1"" mentioned in this context as both proteins are stated to play a role in regulating PDGF transcription, with Sp3 being among the positive regulatory elements while WT-1 is among the negative controlling elements. Additionally, Sp1 is mentioned to have cooperative interactions with Sp3, which indirectly involves the relationship between Sp1, Sp3, and WT-1 in influencing PDGF transcription."
15297375	Sp3	Ets-1	Yes (The relationship between Sp3 and Ets-1 is established through their cooperative interactions with each other in activating PDGF transcription in vascular SMCs.)
15297375	Egr-1	GCF2	"Yes, there is an explicit relationship between ""Egr-1"" and ""GCF2"" mentioned in the given context as both are described to positively and negatively regulate PDGF expression respectively. In addition, ""Ets-1"" is also shown to have a direct relationship with ""Sp1"" in the context, as they cooperatively activate PDGF transcription."
15297375	Egr-1	NF-1	"Yes (There is an explicit relationship between Egr-1 and NF-1 mentioned in the text, as they both positively and negatively regulate PDGF expressions, respectively)"
15297375	Egr-1	WT-1	"Yes (The context explicitly describes that Ets-1 cooperatively activates PDGF transcription with Sp1, and Sp1 interacts with Ets-1 in regulating the PDGF promoter, while the presence of an Ets-1 binding site in the PDGF promoter is also mentioned.)"
15297375	Egr-1	Ets-1	"Yes (Ets-1 and Sp1 have a cooperative relationship in activating PDGF transcription in vascular SMCs, as mentioned in the context.)"
15297375	GCF2	NF-1	"No, the explicit relationship between ""GCF2"" and ""NF-1"" in this context is not mentioned. Both GCF2 and NF-1 are mentioned as negative regulators of PDGF expression independently."
15297375	GCF2	WT-1	"No, in the given context, Ets-1 is explicitly shown to have a relationship with the PDGF (platelet-derived growth factor) transcription and is involved in growth stimulation in smooth muscle cells. Although WT-1 is mentioned amongst factors negatively controlling PDGF transcription, there is no explicit direct relationship mentioned between WT-1 and GCF2, and there's also no data on WT-1's relationship with Ets-1. So, the answer is ""no"" for an explicit relationship between GCF2 and WT-1 mentioned in the text. The answer for an explicit relationship between Ets-1 and WT-1 is also ""no""."
15297375	GCF2	Ets-1	"Yes, there is an explicit relationship between ""GCF2"" and the context as it is mentioned as a negative regulator of PDGF expression. However, the explicit relationship mentioned in the text between ""GCF2"" and ""Ets-1"" is absent. The text explicitly establishes a relationship between ""Ets-1"" and ""Egr-1"", ""Sp1"", ""Sp3"", and the ""PDGF expression"". Hence, the explicit relationship stated between ""Ets-1"" and the context is present, but it is not with ""GCF2""."
15297375	NF-1	WT-1	"Yes, there is an explicit relationship between ""NF-1"" and the PDGF transcription as the text mentioned that ""PDGF expression is under the positive regulatory influence of Sp1, Sp3, and Egr-1 and is negatively controlled by GCF2, NF-1, and WT-1."" Although there isn't a direct relationship between NF-1 and WT-1 explicitly described, they are both negatively controlling PDGF transcription. Similarly, an explicit relationship between ""WT-1"" and the PDGF transcription is established in the same manner."
15297375	NF-1	Ets-1	Yes (Ets-1 and Sp1 have a cooperative relationship in activating PDGF transcription in vascular SMCs as mentioned in the given context.)
15297375	WT-1	Ets-1	"Yes, there is an explicit relationship between ""WT-1"" and the context, as they mention that WT-1 is one of the factors that negatively controls the PDGF transcription. However, the given text does not explicitly establish a relationship between ""WT-1"" and ""Ets-1"" directly. Instead, the main relationship highlighted in the text is between Ets-1 and Sp1 in the regulation of PDGF expression and SMC growth."
15307176	CD46	CD3	"Yes, there is an explicit relationship between ""CD46"" and ""CD3"" as CD46 mediated costimulation enhances TCR CD3 signaling in human CD4+ T lymphocytes and can affect the secretion of various cytokines, contributing to a Th1-biased response in these cells."
15307176	CD46	CD28	"Yes, there is an explicit relationship between ""CD46"" and ""CD28"" as the text mentions that ""coligation of CD3 and CD46 in the presence of PMA or CD28 costimuli enhanced IL-2, IFN-gamma, or IL-10 secretion by CD4+ T lymphocytes."" This indicates that CD46 works together with CD28 to enhance specific cell reactions. However, keep in mind that this relationship doesn't necessarily represent any causative or direct physical interaction between the two pathways, but rather their involvement in an overlapping or coordinated process in T cell activation."
15307176	CD46	IL-2	"Yes, there is an explicit relationship between ""CD46"" and ""IL-2"" because CD46 costimulation enhances IL-2 secretion by CD4+ T lymphocytes in certain situations. This relationship, however, is limited to the context provided and may not indicate a generalized relationship."
15307176	CD46	IFN-gamma	"Yes, there is an explicit relationship between ""CD46"" and ""IFN-gamma"" as CD46 mediated costimulation enhances early TCR CD3 signaling and contributes to augmented IFN-gamma secretion, promoting a Th1-biased response in human CD4+ T lymphocytes."
15307176	CD46	IL-10	"Yes, there is an explicit relationship between ""CD46"" and ""IL-10"" as CD46 costimulation enhanced IL-10 secretion by CD4+ T lymphocytes without requiring additional costimuli like anti-CD28 antibodies or phorbol esters. This effect was independent of IL-12 and contributed to promoting a Th1-biased response in human CD4+ T lymphocytes."
15307176	CD46	IL-5	"Yes, there is an explicit relationship between ""CD46"" and ""IL-5"" as the text states that ""IL-5 secretion was inhibited upon CD46 CD3 coligation"" and further explains that this effect contributes to the Th1 bias."
15307176	CD46	TCR	"Yes, there is an explicit relationship between ""CD46"" and ""TCR"" as CD46 mediated costimulation enhances early TCR CD3 signaling in human CD4+ T lymphocytes."
15307176	CD46	CD3zeta	"No, there is no explicit direct relationship described between CD46 and CD3zeta in the given context besides CD46 enhancing the TCR CD3 induced tyrosine phosphorylation of CD3zeta."
15307176	CD46	ZAP-70	"Yes, CD46 is explicitly mentioned to enhance TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70."
15307176	CD46	ERK	"Yes, in this context, CD46 is shown to enhance the activation of the ERK (extracellular signal-regulated kinase) pathway due to its role in mediated costimulation and early TCR CD3 signaling. So, a direct relationship exists between CD46 and the activation of the ERK pathway in human CD4+ T lymphocytes. Answer: yes."
15307176	CD46	JNK	"Yes, in this context, ""CD46"" has an explicit relationship with ""JNK"" because it enhances TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, and activation of the ERK, JNK, and p38. However, there is no direct or explicit relationship between CD46 and JNK described when causing cellular proliferation or lymphokine secretion specifically. So, the answer would be ""yes"" for the specific pathway mentioned."
15307176	CD46	p38	"Yes, in this context, there is an explicit relationship between ""CD46"" and ""p38"" since CD46 enhanced TCR CD3-induced activation of ERK, JNK, and p38."
15307176	CD3	CD28	"Yes (CD3 and CD46 have an explicit relationship in terms of enhancing TCR CD3 signaling, promoting IL-2, IFN-gamma, and IL-10 secretion, and affecting IL-5 secretion when coligated. CD28 is also mentioned as a costimulus showing interaction with CD3 and CD46 in some contexts.)"
15307176	CD3	IL-2	"Yes, there is an explicit relationship between CD3 and IL-2 in the given context. Coligation of CD3 and CD46 signaling enhances the secretion of IL-2 by CD4+ T lymphocytes, particularly contributing to a Th1-biased response."
15307176	CD3	IFN-gamma	"Yes, there is an explicit relationship between ""CD3"" and ""IFN-gamma"" as the text mentions that CD46 mediated costimulation enhances early TCR CD3 signaling, which ultimately leads to enhanced IFN-gamma secretion by CD4+ T lymphocytes."
15307176	CD3	IL-10	"Yes, there is an explicit relationship between ""CD3"" and ""IL-10"" as it mentions that CD46, when coligated with CD3, can enhance IL-2, IFN-gamma, and IL-10 secretion. Additionally, the effect of CD46 on IL-10 secretion does not require additional costimuli like anti-CD28 antibodies or phorbol esters. This suggests a connection between CD3 and IL-10 when the presence of CD46 costimulation is involved."
15307176	CD3	IL-12	"Yes, there is an indirect relationship between ""CD3"" and ""IL-12"" mentioned in this context as enhanced IL-2 and IFN-gamma secretion, which can be affected by CD46 coligation with CD3 stimulation, do not require IL-12. This suggests that CD46 costimulation promotes a Th1-biased response influenced by CD3 interaction, even though IL-12 is not directly needed in this relationship."
15307176	CD3	IL-5	"Yes, there is an explicit relationship between ""CD3"" and ""IL-5"" as the text states that ""IL-5 secretion was inhibited upon CD46 CD3 coligation."" This indicates a direct effect between the activation of CD3 and the secretion of IL-5."
15307176	CD3	TCR	"Yes, there is an explicit relationship between ""CD3"" and ""TCR"" as the text mentions that CD46 costimulation enhances early TCR CD3 signaling in human CD4+ T lymphocytes. Additionally, CD46 enhances TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70."
15307176	CD3	CD3zeta	"No, the explicit relationship between ""CD3"" and ""CD3zeta"" in this context is that CD46 costimulation enhances TCR CD3 induced tyrosine phosphorylation of CD3zeta. However, this relationship is not directly between CD3 and CD3zeta, but between TCR CD3 signaling (which involves CD3) and CD3zeta."
15307176	CD3	ZAP-70	"Yes, there is an explicit relationship between ""CD3"" and ""ZAP-70"" mentioned in the context, as CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70."
15307176	CD3	ERK	"Yes, there is an explicit relationship between ""CD3"" and ""ERK"" in the text. CD46 costimulation enhances the early TCR CD3 signaling which results in the activation of ERK (among other pathways). The enhanced ERK activation contributes to altered cytokine production, specifically higher IFN-gamma and lower IL-5, leading to a Th1-biased response in human CD4+ T lymphocytes."
15307176	CD3	JNK	"Yes (There is an explicit relationship between ""CD3"" and ""JNK"" as CD46 costimulation enhances TCR CD3 induced activation of JNK.)"
15307176	CD3	p38	"Yes, in this context, CD3 and p38 are related in the sense that CD46 costimulation enhances TCR CD3-induced signaling, which includes the activation of ERK, JNK, and p38 pathways. So, the answer is ""yes"". However, it's worth noting that CD3 and p38's relationship is indirect, as it is mediated through the TCR (T cell receptor) and CD3zeta signaling molecules."
15307176	CD28	IL-2	"Yes, there is an explicit relationship between ""CD28"" and ""IL-2"" mentioned in the context as the coligation of CD3 and CD46 in the presence of PMA or CD28 costimuli enhanced IL-2 secretion by CD4+ T lymphocytes."
15307176	CD28	IFN-gamma	"Yes, CD28 is mentioned as a costimuli that enhances IL-2, IFN-gamma, or IL-10 secretion when coligated with CD3 in the presence of human CD4+ T lymphocytes. This directly connects CD28 to the secretion of IFN-gamma."
15307176	CD28	IL-10	"Yes, there is an explicit relationship between CD28 and IL-10 mentioned in the context, where it states that ""the effect of CD46 on IL-10 secretion did not require additional costimuli like anti-CD28 antibodies or phorbol esters."" Although CD28 is not directly binding to IL-10, there is a connection between the effects of CD28 as an additional costimulatory signal and the IL-10 secretion process."
15307176	CD28	IL-12	"Yes, there is an explicit relationship between ""CD28"" and ""IL-12"" in the given context because the text mentions that ""Coligation of CD3 and CD46 in the presence of PMA or CD28 costimuli enhanced IL-2, IFN-gamma, or IL-10 secretion by CD4+ T lymphocytes"" and also notes that the enhanced effects were ""independent of IL-12."""
15307176	CD28	IL-5	"No, the explicit relationship between ""CD28"" and ""IL-5"" described in this context is that CD46 coligation of CD3 inhibited IL-5 secretion, which requires additional costimuli like anti-CD28 antibodies for some other effects on secretion (IL-2, IFN-gamma or IL-10) but not for this inhibitory effect on IL-5."
15307176	CD28	TCR	"Yes, there is an explicit relationship between ""CD28"" and ""TCR"" as mentioned in the text: coligation of CD3 and CD46 in the presence of PMA (Phorbol 12-myristate 13-acetate) or CD28 costimuli enhanced cytokine secretion by CD4+ T lymphocytes. This highlights a functional connection between CD28 and TCR CD3 signaling."
15307176	CD28	CD3zeta	"No, the explicit relationship between ""CD28"" and ""CD3zeta"" in this context is not directly mentioned. CD28 is mentioned for costimulation in some scenarios, but the relationship with CD3zeta is not detailed. Instead, CD46's effects on CD3zeta phosphorylation are described."
15307176	CD28	ZAP-70	"No, in this context, CD46 (membrane cofactor protein, CD46) is shown to enhance early TCR CD3 signaling which includes the tyrosine phosphorylation of CD3zeta and ZAP-70. While CD46 is directly related to ZAP-70 through this process, the explicit relationship between CD28 and ZAP-70 is not described within this text. So, the answer is ""no"" for an explicit relationship between CD28 and ZAP-70 in this context."
15307176	CD28	ERK	"No, in the given context, CD28 is mentioned for enhancing early TCR CD3 signaling and inducing certain responses when coligated with CD3. CD46 mediated costimulation is also discussed. CD46 indirectly enhances ERK activation, which in turn contributes to the augmented IFN-gamma and lower IL-5 secretion leading to a Th1-biased response. Although CD28 and ERK are mentioned and a relationship with ERK is shown through CD46 costimulation, CD28 itself does not have an explicitly described direct relationship with ERK in this context. Answer: No (there is no explicitly described direct relationship between CD28 and ERK in this context)"
15307176	CD28	JNK	"No, CD28 is not explicitly related to JNK in the given context. The relationships between CD46 and JNK through its effect on the activation of MAP kinases like JNK are mentioned, but there's no direct relationship described between CD28 and JNK."
15307176	CD28	p38	"No, the explicit relationship between ""CD28"" and ""p38"" is not mentioned in this context. Although CD28 is described as a costimulus that enhances T cell activation and p38 is mentioned as being activated during CD46-enhanced TCR CD3 signaling, there is no direct relationship stated between these two molecules."
15307176	IL-2	IFN-gamma	"Yes, there is an explicit relationship between ""IL-2"" and ""IFN-gamma"" mentioned in the context as both are lymphokines (secretion by CD4+ T lymphocytes) and their secretion is enhanced by CD46 mediated costimulation in the presence of PMA or CD28 costimuli."
15307176	IL-2	IL-10	"Yes (There is a relationship between IL-2 and IL-2 enhancement suggested by CD46 costimulation. Additionally, CD46 enhanced IL-10 secretion by CD4+ T lymphocytes.)"
15307176	IL-2	IL-12	"No (there is no explicit mention of an explicit relationship between ""IL-2"" and ""IL-12"" in the provided text.)"
15307176	IL-2	IL-5	"Yes, in this context, an explicit relationship between ""IL-2"" and ""IL-5"" is that ""the effect of CD46 on CD3 coligation promotes an increase in IL-2 secretion while inhibiting IL-5 secretion in CD4+ T lymphocytes."" This Th1-biased profile suggests some anti-correlation between the two cytokines, although the text does not make a direct causal link between IL-2 and IL-5. So, we can say ""yes"" to the involvement of the CD46 protein in modulating these cytokines, but no direct link between them is explicitly mentioned."
15307176	IL-2	TCR	"Yes, there is an explicit relationship between ""IL-2"" and the context provided as CD46 costimulation enhances IL-2 secretion by CD4+ T lymphocytes in the presence of PMA or CD28 costimuli."
15307176	IL-2	CD3zeta	"Yes, there is an explicit relationship between ""IL-2"" and ""CD3zeta"" as CD46 costimulation enhances TCR CD3 induced tyrosine phosphorylation of CD3zeta and is involved in the increased secretion of IL-2 by CD4+ T lymphocytes."
15307176	IL-2	ZAP-70	"Yes, there is an explicit relationship between ""IL-2"" and ""ZAP-70"" as the text mentions that CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta (which is the alpha chain of the TCR complex) and ZAP-70. Although a specific direct relationship between IL-2 and ZAP-70 is not mentioned, the effects on cytokine secretion such as IL-2 are indirectly related to the enhanced early TCR CD3 signaling involving ZAP-70."
15307176	IL-2	ERK	"Yes (The explicit relationship between ""IL-2"" and ""ERK"" is that enhanced ERK activation contributes to augmented IFN-gamma and lower IL-5 secretion and, consequively, to the Th1 bias which also includes the increased secretion of IL-2.)"
15307176	IL-2	JNK	"No, there is no explicit direct relationship between ""IL-2"" and ""JNK"" mentioned in the given context. However, it is stated that enhanced ERK activation contributes to augmented IFN-gamma and lower IL-5 secretion, which could indirectly relate IL-2 to JNK via ERK activation."
15307176	IL-2	p38	"Yes (In this context, IL-2 secretion is influenced by the role of CD46, which in turn affects the activation of certain pathways like ERK, JNK, and p38. Thus, an explicit relationship is mentioned between IL-2 and p38 via the ERK pathway.)"
15307176	IFN-gamma	IL-10	"Yes, there is an explicit relationship between ""IFN-gamma"" and ""CD46"" through costimulation, as the text indicates that ""CD46 mediated costimulation induces a Th1 biased response"" and ""enhances early TCR CD3 signaling"" leading to augmented IFN-gamma secretion. However, the mentioned relationship between IFN-gamma and IL-10 in this context is indirect, with CD46 mediated costimulation potentially promoting Th1 biased response, which results in increased IFN-gamma and lower IL-5 production."
15307176	IFN-gamma	IL-12	"Yes, there is an implicit relationship between IFN-gamma and IL-12 as the text highlights that CD46 costimulation promotes a Th1-biased response in human CD4+ T lymphocytes, which can involve the production of IFN-gamma. Th1 cells are known to be induced and activated by IL-12, though this specific text does not explicitly mention a direct relationship between IFN-gamma and IL-12. However, as the production of IFN-gamma is related to Th1 response, there is an indirect relationship."
15307176	IFN-gamma	IL-5	"No, the explicit relationship between ""IFN-gamma"" and ""IL-5"" described in this context is that the CD46 costimulation promotes a Th1-biased response, and as a result, inhibits IL-5 secretion upon CD46 CD3 coligation, which correlates with increased IFN-gamma secretion. So, while there is a direct relationship between enhanced IFN-gamma and lower IL-5 secretion obtained through a particular costimulation, they are not directly connected without that context."
15307176	IFN-gamma	TCR	"Yes, there is an explicit relationship between ""IFN-gamma"" and ""TCR"" as CD46 costimulation enhances early TCR CD3 signaling in human CD4+ T lymphocytes, and this effect results in augmented IFN-gamma secretion."
15307176	IFN-gamma	CD3zeta	"Yes, there is an explicit relationship between ""IFN-gamma"" and ""CD3zeta"" as CD46 enhancement of TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70 contributes to augmented IFN-gamma secretion. This relationship shows that CD3zeta, being involved in TCR CD3 activation, has an influence on the production of the cytokine IFN-gamma."
15307176	IFN-gamma	ZAP-70	"No, to answer this question, I focused on the context given, which discusses the effect of membrane cofactor protein (MCP, CD46) on human T cell activation, as well as interactions with CD3zeta and ZAP-70 molecules. CD46 enhances TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70. This indicates that there is an indirect relationship between CD46, via its effect on CD3zeta, and ZAP-70. However, the explicit relationship between ""IFN-gamma"" and ""ZAP-70"" is not directly mentioned in this context. Answer: No (There is no direct explicit relationship between ""IFN-gamma"" and ""ZAP-70"" in this context)"
15307176	IFN-gamma	ERK	"Yes (There is an explicit relationship between IFN-gamma and ERK mentioned in the text, where enhanced ERK activation contributes to augmented IFN-gamma secretion.)"
15307176	IFN-gamma	JNK	"Yes (The explicit relationship between ""IFN-gamma"" and ""JNK"" is that CD46 enhanced TCR CD3 induced activation of JNK, although it does not directly influence IFN-gamma secretion, but an enhanced ERK activation, which is involved in augmented IFN-gamma secretion.)"
15307176	IFN-gamma	p38	"Yes, there is an explicit relationship between ""IFN-gamma"" and ""p38"" as the text mentions ""the effect of specific inhibitors shows that enhanced ERK activation contributes to augmented IFN-gamma..."" and ""activation of the ERK, JNK, and p38."""
15307176	IL-10	IL-12	"No, In this context, it is stated that the effects of CD46 costimulation on IL-2 or IFN-gamma secretion and the inhibition of IL-5 secretion are independent of IL-12. There is, however, no direct explicit relationship between IL-10 and IL-12 described in this text. Thus, based solely on the given context, the relationship between IL-10 and IL-12 cannot be definitively confirmed. Therefore, the answer is ""no""."
15307176	IL-10	IL-5	"Yes, there is an explicit relationship between ""IL-10"" and ""CD46"" as the text states that ""The effect of CD46 on IL-10 secretion did not require additional costimuli like anti-CD28 antibodies or phorbol esters"" and ""CD46 costimulation promotes a Th1-biased response in human CD4+ T lymphocytes."" Additionally, there is also a relationship between ""IL-5"" and ""CD46"" as the text says ""in contrast, IL-5 secretion was inhibited upon CD46 CD3 coligation."" However, there is no explicit relationship mentioned between IL-5 and IL-10 within the given context."
15307176	IL-10	TCR	"No, there is no explicit direct relationship between ""IL-10"" and ""TCR"" described in this context. The relationship among IL-10, CD46, and T cells is mentioned, but it does not include TCR directly."
15307176	IL-10	CD3zeta	"No, there isn't an explicit direct relationship between ""IL-10"" and ""CD3zeta"" mentioned in the text. CD3zeta is described as being involved in TCR CD3 induced tyrosine phosphorylation and as contributing to enhanced ERK activation, which in turn affects IFN-gamma and IL-5 secretion, contributing to the Th1 bias. However, there is no direct connection between IL-10 and CD3zeta established in the provided context."
15307176	IL-10	ZAP-70	"No, there is no explicit direct relationship stated between ""IL-10"" and ""ZAP-70"" in the given context. The text focuses on the role of CD46 (Membrane Cofactor Protein) in human T cell activation, including its effects on IL-2, IFN-gamma, IL-10 secretion, and the relationship with TCR CD3 signaling and other proteins such as ZAP-70. However, IL-10 and ZAP-70 are not directly connected in this context."
15307176	IL-10	ERK	"No, there is no explicit direct relationship between ""IL-10"" and ""ERK"" stated in this context. The text describes that enhanced ERK activation contributes to augmented IFN-gamma secretion and lower IL-5 secretion, influencing the Th1 bias. However, this connection is indirect, through the role of ERK on IFN-gamma and IL-5 secretion, rather than IL-10 directly."
15307176	IL-10	JNK	"No, there is no explicit direct relationship between IL-10 and JNK described in the given context. JNK is mentioned to be activated by CD46 costimulation, and its involvement in the effects on IFN-gamma and IL-5 secretion is described. However, there's no direct or explicit connection between IL-10 and JNK."
15307176	IL-10	p38	"No, there is no explicit direct relationship described between ""IL-10"" and ""p38"" in the provided context, although enhanced ERK activation contributes to augmented IFN-gamma and lower IL-5 secretion, influencing the overall Th1 bias."
15307176	IL-12	IL-5	"No, the explicit relationship between ""IL-12"" and ""IL-5"" in this context is that the CD46 costimulation promotes a Th1-biased response through effects on IL-2, IFN-gamma, and IL-10 secretion that are independent of IL-12, and the inhibition of IL-5 secretion upon CD46 CD3 coligation. However, IL-12 and IL-5 are not directly linked by any other relationship explicitly mentioned."
15307176	IL-12	TCR	"No, in this context, there is no explicit direct relationship mentioned between ""IL-12"" and ""TCR"". IL-12 is only mentioned in relation to the independent effect of CD46 costimulation on IL-2, IFN-gamma, and IL-10 secretion."
15307176	IL-12	CD3zeta	"No, in this context, there is no explicit relationship mentioned between ""IL-12"" and ""CD3zeta"". The relationship between CD46 costimulation and Th1 cell polarization in terms of IL-2, IFN-gamma, and IL-10 secretion is described, but not between IL-12 and CD3zeta."
15307176	IL-12	ZAP-70	"No, there is no explicit direct relationship stated between ""IL-12"" and ""ZAP-70"" in the given context. IL-12 is mentioned in relation to the suggested Th1-biased effect of CD46 costimulation, while ZAP-70 is mentioned as a protein experiencing tyrosine phosphorylation because of CD46 costimulation and its role in enhanced IFN-gamma production through ERK activation."
15307176	IL-12	ERK	"No, the explicit relationship between ""IL-12"" and ""ERK"" in this context is not mentioned. IL-12 is related to the Th1-biased response, while ERK is related to enhanced IFN-gamma secretion and lower IL-5 secretion resulting in the Th1 bias."
15307176	IL-12	JNK	"No, there is no explicit direct relationship between ""IL-12"" and ""JNK"" described in this context. IL-12 is mentioned in relation to the effect of CD46 costimulation on the Th1-biased response, while JNK activation is described as being enhanced by CD46 in the context of TCR CD3 signaling. However, they are not directly linked to each other."
15307176	IL-12	p38	"No, the relationship between ""IL-12"" and ""p38"" is not explicitly described in this context. Both molecules are mentioned separately, but their relationship is not established."
15307176	IL-5	TCR	"Yes, there is an explicit relationship between ""IL-5"" and the context described, as the text mentions that CD46 costimulation inhibited IL-5 secretion upon CD46 CD3 coligation. However, there is no explicit relationship described between ""IL-5"" and ""TCR"". The relationship between CD46 and TCR is described through enhanced early TCR CD3 signaling, particularly with tyrosine phosphorylation of CD3zeta and ZAP-70. However, the direct and explicit connection between ""TCR"" and ""IL-5"" is not mentioned in this context."
15307176	IL-5	CD3zeta	"No, while the text describes the influence of CD46 (membrane cofactor protein, or CD46) on the regulation of several signaling molecules (like CD3zeta) and various cytokines (including IL-5) in human CD4+ T lymphocytes, there is no explicit relationship directly stated between IL-5 and CD3zeta in this context."
15307176	IL-5	ZAP-70	Yes (The relationship between IL-5 and the early TCR CD3 signaling involving ZAP-70 is indirectly shown in the text as CD46 costimulation enhances ZAP-70 and biases towards a Th1 response leading to lower IL-5 secretion.)
15307176	IL-5	ERK	"Yes, there is an explicit relationship between IL-5 and ERK, as the text mentions that enhanced ERK activation contributes to augmented IFN-gamma and lower IL-5 secretion and promotes a Th1-biased response."
15307176	IL-5	JNK	"No, there is no explicit direct relationship mentioned between ""IL-5"" and ""JNK"" in this context. An indirect relationship can be inferred as the enhanced ERK activation (an effect of CD46 costimulation) contributes to the modulation of both augmented IFN-gamma and lowered IL-5 secretion."
15307176	IL-5	p38	"No, there is no explicit direct relationship between ""IL-5"" and ""p38"" mentioned in the given context. However, it is mentioned that enhanced ERK activation (not p38 directly) contributes to augmented IFN-gamma and lower IL-5 secretion, leading to a Th1 bias."
15307176	TCR	CD3zeta	"Yes, there is an explicit relationship between ""TCR"" and ""CD3zeta"" as the text states that CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta."
15307176	TCR	ZAP-70	"Yes, there is an explicit relationship between ""TCR"" and ""ZAP-70"" mentioned in the text, as it states that CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70."
15307176	TCR	ERK	"Yes, there is an explicit relationship between ""TCR"" and ""ERK"" in the given context. CD46 costimulation enhances the activation of ERK in response to TCR CD3 signaling, and enhanced ERK activation contributes to the secretion of cytokines such as IFN-gamma and inhibits IL-5 secretion, resulting in a Th1-biased response in human CD4+ T lymphocytes."
15307176	TCR	JNK	"Yes, in the given context, there is an explicit relationship between ""TCR"" (T-cell receptor) and ""JNK"" (c-Jun N-terminal kinase) through their involvement in the signaling pathways. CD46 costimulation enhances TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, which also leads to the activation of signaling molecules like JNK. This activation of JNK contributes to the differential secretion of cytokines in a Th1-biased response in human CD4+ T lymphocytes."
15307176	TCR	p38	"Yes, an explicit relationship between ""TCR"" and ""p38"" is mentioned in the text. CD46 enhances TCR CD3 induced activation of the ERK, JNK, and p38, indicating a connection between TCR and p38."
15307176	CD3zeta	ZAP-70	Yes (CD46 enhances TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70)
15307176	CD3zeta	ERK	"Yes, there is an explicit relationship between ""CD3zeta"" and ""ERK"" as the text mentions that CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and the activation of ERK. The use of specific inhibitors further suggests a contribution of enhanced ERK activation to augmented IFN-gamma and lower IL-5 secretion, resulting in a Th1 bias."
15307176	CD3zeta	JNK	"Yes, there is an explicit relationship between ""CD3zeta"" and ""JNK"" in this context as the activation of JNK is mentioned to be part of the signaling events enhanced by CD46 coligation with CD3."
15307176	CD3zeta	p38	"Yes, there's an explicit relationship between ""CD3zeta"" and ""p38"" mentioned in the text as CD46 costimulation enhances TCR CD3 induced tyrosine phosphorylation of CD3zeta and the activation of the ERK, JNK, and p38."
15307176	ZAP-70	ERK	"Yes (There is an explicit relationship between ""ZAP-70"" and ""ERK"" as CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, and the activation of the ERK.)"
15307176	ZAP-70	JNK	"Yes (The relationship between ZAP-70 and the activation of ERK mentioned in the text indirectly connects ZAP-70 to JNK since ERK, JNK, and p38 are all mentioned together as activated by CD46 costimulation.)"
15307176	ZAP-70	p38	"Yes (There is an explicit relationship between ""ZAP-70"" and ""p38"" as CD46 enhanced TCR CD3 induced tyrosine phosphorylation of CD3zeta and ZAP-70, which led to the activation of the ERK, JNK, and p38.)"
15307176	ERK	JNK	"Yes (ERK and JNK activations are explicitly mentioned as being enhanced by CD46 in the context of TCR CD3 signaling; however, the relationship between these two proteins is not specifically defined beyond both being activated.)"
15307176	ERK	p38	"Yes, there is an explicit relationship between ""ERK"" and ""p38"" mentioned in the text, as CD46 costimulation enhanced the activation of both ERK and p38 in the context of TCR CD3 signal transmission."
15307176	JNK	p38	"Yes (The text states that CD46 enhances activation of the ERK, JNK, and p38 pathways.)"
15309723	PDGF	IL-10	"Yes (The given text establishes an explicit relationship between PDGF and IL-10 in terms of their effects on the expressions of FasL, Bcl-2, and Bax in rat hepatic stellate cells, which may contribute to IL-10's antifibrosis mechanism.)"
15309723	PDGF	FasL	"Yes, ""PDGF"" and ""FasL"" have an explicit relationship in the given context as FasL mRNA levels change when hepatic stellate cells are treated with PDGF alone, IL-10 alone, or their combination. However, there is no direct explicit relationship between PDGF and Fas mentioned in the text. Similarly, ""IL-10"" is directly linked with the up-regulation of ""FasL"" and ""Bax"" expressions, providing an explicit relationship between these factors."
15309723	PDGF	Bcl-2	"Yes, in this context, PDGF and Bcl-2 are explicitly related through their combined interaction with IL-10 in affecting Bcl-2 mRNA expression levels in rat hepatic stellate cells. PDGF, alone or in combination with IL-10, down-regulates Bcl-2 mRNA expression while up-regulating Bax mRNA expression in these cells."
15309723	PDGF	Bax	"Yes, in this context, PDGF (platelet-derived growth factor) and Bax seem to have an explicit relationship. PDGF may not significantly affect HSC apoptosis directly, but when combined with IL-10, it leads to down-regulation of Bcl-2 mRNA and up-regulation of Bax mRNA expression, which might participate in promoting apoptosis in rat hepatic stellate cells (HSCs). IL-10 alone promotes apoptosis in HSCs through up-regulating the expressions of FasL and Bax and down-regulating the expression of Bcl-2."
15309723	IL-10	Fas	"Yes, in this context, there is an explicit relationship between ""IL-10"" and the ""up-regulation"" of ""FasL (Fas-ligand)"" expression as IL-10 increases the level of FasL mRNA in HSCs. Additionally, IL-10 is also related to the regulation of Bcl-2 and Bax, which have connections with Fas, as it promotes HSC apoptosis by up-regulating Bax and down-regulating Bcl-2, potentially influencing the Fas pathway in HSC apoptosis indirectly."
15309723	IL-10	FasL	"Yes, there is an explicit relationship between ""IL-10"" and ""FasL"" as IL-10 is stated to up-regulate FasL expression, suggesting its potential role in promoting apoptosis in hepatic stellate cells. Additionally, there is also an indirect relationship between IL-10 and FasL through its effect on Bcl-2 and Bax expressions which play a role in regulating apoptosis."
15309723	IL-10	Bcl-2	Yes
15309723	IL-10	Bax	"Yes, in the given context, there is an explicit relationship between ""IL-10"" and ""Bax"" as IL-10 is suggested to promote apoptosis in HSCs by up-regulating the expressions of FasL and Bax."
15309723	Fas	FasL	"No, the specific relationship between Fas and FasL as described in this context is only that FasL mRNA increased in HSCs (hepatic stellate cells) after treating with IL-10. However, this increase in FasL did not result from direct interaction with Fas but might be part of the mechanism by which IL-10 promotes apoptosis in HSCs."
15309723	Fas	Bcl-2	"Yes, in this context, there is an explicit relationship between ""FasL"" (Fas ligand) and IL-10, as the text mentions that IL-10 significantly increased the FasL mRNA level in cultured HSCs (group I). Additionally, there is an explicit relationship between ""Bcl-2"" and ""Bax,"" as well as with PDGF and IL-10, since these factors alter the expressions of both proteins. Both Bcl-2 and Bax are involved in the apoptosis of HSCs, and PDGF and IL-10 impact their expressions differently. However, the text does not describe an explicit relationship between ""Fas"" and ""Bcl-2"" or between ""Fas"" and IL-10. Therefore, the answer is ""no"" for ""Fas"" and ""Bcl-2"" and ""no"" for ""Fas"" and IL-10."
15309723	Fas	Bax	"No, there is no explicit direct relationship described between ""Fas"" and ""Bax"" in the given context. While the text mentions changes in Bcl-2 and Bax expressions, the effects of PDGF and IL-10 on Fas and FasL are mostly discussed separately."
15309723	FasL	Bcl-2	"Yes (based on the text, there is a relationship between IL-10, FasL, and Bcl-2/Bax mRNA expressions in rat hepatic stellate cells, with IL-10 affecting their expressions which may lead to the promotion of apoptosis in HSCs.)"
15309723	FasL	Bax	"No (There is no explicit relationship between FasL and Bax described in the given context. FasL and Bax/Bcl-2 expressions are mentioned separately, but their direct relationship is not stated.)"
15309723	Bcl-2	Bax	"Yes, there is an explicit relationship between ""Bcl-2"" and ""Bax"" mentioned in the text where it describes their expressions being regulated by PDGF and IL-10, implying a connection between these proteins in the context of HSC activation and apoptosis. Additionally, changes in the expression levels of Bcl-2 and Bax are compared between the different treatment groups."
15319285	GILZ	Bcl-xL	"Yes, there is an explicit relationship between ""GILZ"" and ""Bcl-xL"" described in this context. GILZ (glucocorticoid-induced leucine zipper) is shown to have a connection with Bcl-xL, an antiapoptotic protein. In the experimental results, decreased Bcl-xL expression and increased thymocyte apoptosis were observed in GILZ overexpressing transgenic mice. In wild-type thymocytes, the up-regulation of GILZ led to sequential decreased Bcl-xL expression and activation of caspase-8 and caspase-3. Additionally, delivering GILZ inside wild-type thymocytes by a fusion protein also resulted in decreased Bcl-xL expression, promoting their apoptosis."
15319285	GILZ	caspase-8	"Yes, there is an explicit relationship between ""GILZ"" and ""caspase-8"" described in the context. GILZ up-regulation leads to sequential Bcl-xL decreased expression and the activation of caspase-8 and caspase-3. Also, GILZ delivered inside WT thymocytes decreases Bcl-xL and promotes their apoptosis involving caspase-8 activation."
15319285	GILZ	caspase-3	"Yes, there is an explicit relationship between ""GILZ"" and ""caspase-3"" as the context discusses how GILZ up-regulation in wild-type thymocytes leads to sequential Bcl-xL decreased expression and activation of caspase-8 and caspase-3. Additionally, GILZ delivered inside wild-type thymocytes by a fusion protein decreased Bcl-xL and promoted their apoptosis involving caspase-3."
15319285	GILZ	TAT	"Yes (GILZ is related to TAT through the delivery of GILZ inside WT thymocytes by a fusion protein with the TAT peptide, leading to decreased Bcl-xL expression and promotion of thymocyte apoptosis)"
15319285	Bcl-xL	caspase-8	"Yes, there is an explicit relationship between Bcl-xL and caspase-8 mentioned in the text as reduced Bcl-xL expression leads to increased activation of caspase-8 and caspade-3 in the apoptotic pathway."
15319285	Bcl-xL	caspase-3	"Yes, there is an explicit relationship described between Bcl-xL and caspase-3 in this context. The decrease in Bcl-xL expression is linked to increased activation of caspase-8 and caspase-3 in the apoptotic pathway."
15319285	Bcl-xL	TAT	"Yes, there is an explicit relationship described between ""Bcl-xL"" and ""TAT"" in this context, as GILZ delivered inside wild-type thymocytes using a fusion protein with the TAT peptide led to decreased Bcl-xL and promoted their apoptosis."
15319285	caspase-8	caspase-3	"Yes, there is an explicit relationship between ""caspase-8"" and ""caspase-3"" in this context, as the increased activation of caspase-8 was followed by activation of caspase-3."
15319285	caspase-8	TAT	Yes (The relationship between caspase-8 and TAT is indirect through the context of the TAT peptide being used as a carrier for delivering GILZ into the cells of wild-type mice which results in decreased Bcl-xL and activation of caspase-8 and caspase-3.)
15319285	caspase-3	TAT	"Yes, there is an explicit relationship between ""caspase-3"" and the context provided as caspase-3 activation is increased in transgenic mice overexpressing GILZ, and its activation follows the sequential decrease in Bcl-xL expression. Delivering GILZ inside WT thymocytes by a fusion protein with the TAT peptide also decreased Bcl-xL and promoted their apoptosis."
15319299	COX-2	ERK	"Yes, there is an explicit relationship between ""COX-2"" and ""ERK"" in this context. This relationship involves the sequential activation of the ERK/COX-2/VEGF signaling pathway where nicotine stimulates gastric tumor growth and neovascularization through the activation of extracellular signal-regulated kinase (ERK) and cyclooxygenase-2 (COX-2)."
15319299	COX-2	PCNA	"Yes, there is an explicit relationship between ""COX-2"" and ""PCNA"" mentioned in the text. Nicotine increased proliferating cellular nuclear antigen (PCNA) staining in the tumors, and this connection was also supported by the evidence found from both animal models and in vitro studies. The activation of the ERK/COX-2/VEGF signaling pathway was involved in this relationship."
15319299	COX-2	VEGF	"Yes, there is an explicit relationship between ""COX-2"" and ""VEGF"" in this context as COX-2 expression and subsequent prostaglandin E(2) (PGE(2)) release are shown to be activated by nicotine and lead to an increase in angiogenic factor VEGF production through a sequential activation of the ERK/COX-2/VEGF signaling pathway."
15319299	COX-2	PGE(2)	"Yes, the text explicitly connects COX-2 and PGE(2), as it explains that nicotine increases COX-2 expression and subsequently leads to the increase in prostaglandin E(2) (PGE(2)) release in cells."
15319299	ERK	PCNA	"Yes, there is an explicit relationship between ""ERK"" and ""PCNA"" as the text mentions that nicotine treatment increased proliferating cellular nuclear antigen (PCNA) staining with concomitant activation of ERK phosphorylation in tumors. However, it does not directly state a relationship between ERK and PCNA as a pathway or process, only that these two proteins are activated together in tumors as a result of nicotine treatment."
15319299	ERK	VEGF	"Yes, there is a relationship described between ""ERK"" and ""VEGF"" in this context. The activation of ERK phosphorylation is connected to COX-2 expression and vascular endothelial growth factor (VEGF) expression in the tumors. Additionally, the stimulatory action of nicotine on cancer cell growth and production of the angiogenic factor VEGF is suppressed by inhibitors of MEK (ERK's upstream kinase) and COX-2."
15319299	ERK	PGE(2)	"Yes, an explicit relationship is described between ERK and COX-2, where activation of ERK leads to increased COX-2 expression, which further influences prostaglandin E(2) (PGE(2)) and vascular endothelial growth factor (VEGF) levels. This ERK/COX-2/VEGF signaling pathway plays a role in the promoting action of nicotine on gastric tumor growth and neovascularization. While PGE(2) is linked to COX-2, there is no direct relationship mentioned between PGE(2) and ERK."
15319299	PCNA	VEGF	"Yes, there is an explicit relationship between ""PCNA"" (proliferating cellular nuclear antigen) and the promoting action of nicotine on gastric tumor growth, as well as between ""VEGF"" (vascular endothelial growth factor) and the promoting action of nicotine on neovascularization. Both PCNA staining and microvessel density (associated with VEGF) increased by 70% and 30% respectively due to nicotine treatment, with concomitant activation of ERK phosphorylation and COX-2 expression in the tumors."
15319299	PCNA	PGE(2)	"Yes, there is an explicit relationship between ""PCNA"" (proliferating cellular nuclear antigen) and the effect of nicotine on tumor growth, as Nicotine increases PCNA staining of tumors, likely as a result of promoting cell proliferation. Similarly, there is a relationship between ""PGE(2)"" (prostaglandin E(2)), COX-2, and nicotine: nicotine increases COX-2 expression and PGE(2) release, and inhibition of COX-2 attenuates nicotine-induced tumor growth. This action of nicotine happens through the ERK/COX-2/VEGF signaling pathway."
15319299	VEGF	PGE(2)	"Yes, there is an explicit relationship between ""VEGF"" and ""PGE(2)"" mentioned in the text as both are angiogenic factors influenced by nicotine through the ERK/COX-2 pathway. The activation of ERK phosphorylation and COX-2 expression by nicotine results in increased VEGF and PGE(2) release, which contributes to cancer cell growth and neovascularization."
22504285	XBP-1	HMGB1	Yes
22504285	XBP-1	CD80	"Yes, there is an explicit relationship between ""XBP-1"" and ""CD80"" described in the given context. Gene silencing of XBP-1 in dendritic cells (DCs) results in decreased levels of CD80 expression, among other markers and functions, after stimulation with HMGB1."
22504285	XBP-1	CD86	"Yes (This relationship exists as XBP-1 gene silencing reduces CD80, CD86 expression, and functional impairment in dendritic cells after HMGB1 treatment, suggesting that XBP-1 has an impact on CD86.)"
22504285	XBP-1	MHC-II	"Yes (The explicit relationship describes that gene silence of XBP-1 in splenic DCs decreased the levels of MHC-II expression after HMGB1 treatment, highlighting a connection between XBP-1 and MHC-II in this context.)"
22504285	XBP-1	RAGE	"No, there is no explicit relationship between XBP-1 and RAGE described as a direct interaction or causation in this context. Instead, it is mentioned that gene silence of XBP-1 resulted in down-regulation of RAGE expression on DCs induced by HMGB1 stimulation."
22504285	HMGB1	CD80	"Yes, in this context, there is an explicit relationship between ""HMGB1"" and ""CD80"" through XBP-1 silencing. HMGB1 stimulation leads to increased CD80 expression in dendritic cells, and silencing the XBP-1 gene reduces that expression when compared to untransfected or nontargeting-transfected DCs. This relationship is mediated by XBP-1. Answer: yes"
22504285	HMGB1	CD86	"Yes, there is an explicit relationship between ""HMGB1"" and ""CD86"" as gene silence of XBP-1 influenced the levels of CD80, CD86 expressions, and its silenced DCs failed to stimulate notable proliferation and differentiation of T cells after HMGB1 treatment."
22504285	HMGB1	MHC-II	"Yes, there is an explicit relationship between ""HMGB1"" and ""MHC-II"" as the level of major histocompatibility complex MHC-II expression is affected by gene silence of XBP-1 in DCs after HMGB1 treatment, and DCs play a crucial role in the interaction between HMGB1 and MHC-II in the process of T cell stimulation and differentiation."
22504285	HMGB1	RAGE	"Yes, to answer the given question, I analyzed the text context provided. Although HMGB1 induces maturation and activation of DC, the explicitly mentioned relationship between HMGB1 and RAGE is the fact that gene silence of XBP-1, a regulator involved in HMGB1-induced DC maturation and activation, results in down-regulation of RAGE expression on splenic DCs. Therefore, based on the explicit relationship explained in the given text, my answer is: yes, there is a relationship between HMGB1 and RAGE, mediated through XBP-1."
22504285	CD80	CD86	"No, in this context, CD80 and CD86 are mentioned to be down-regulated when the gene silence of XBP-1 is conducted in splenic DCs after HMGB1 treatment, implying a connection between XBP-1, HMGB1, and the expression of CD80 and CD86. Since CD80 and CD86 are both molecules that play a role in DC maturation and activation, there is an indirect relationship between them through the actions of XBP-1 and HMGB1. However, the text does not provide a direct explicit relationship between CD80 and CD86. So the answer is ""no"" for a direct explicit relationship, but an indirect relationship can be inferred."
22504285	CD80	MHC-II	"Yes, the context suggests an explicit relationship between the molecules CD80, CD86 (as they're mentioned together as markers), and MHC-II, and XBP-1. When XBP-1 is gene silenced in splenic DCs, the levels of CD80, CD86, and MHC-II expression decreased after HMGB1 treatment. Thus, XBP-1 seems to regulate these molecules' expression in DCs. However, there is not any direct relationship explicitly described between XBP-1 and CD80 or MHC-II as independent molecules."
22504285	CD80	RAGE	"No, there is no explicit relationship between ""CD80"" and ""RAGE"" in the given context. The relationship between XBP-1 and RAGE is explicitly mentioned, but not between CD80 and RAGE."
22504285	CD86	MHC-II	"Yes, CD80, CD86, and major histocompatibility complex MHC-II (MHC-II) are explicitly related in this context, as gene silence of XBP-1 led to decreased expression of CD80, CD86, and MHC-II upon HMGB1 treatment in dendritic cells."
22504285	CD86	RAGE	"No, there is no explicit direct relationship between ""CD86"" and ""RAGE"" described in the context. The relationship between XBP-1 and both CD86 and RAGE is mentioned, but none directly between CD86 and RAGE."
22504285	MHC-II	RAGE	"No, there is no explicit relationship described between ""MHC-II"" and ""RAGE"" in this context. RAGE is shown to have a relationship with XBP-1 and is affected by it during DC maturation following HMGB1 stimulation, while MHC-II is associated with ERS markers and XBP-1 in regulating DC activation."
22516229	FSH	GDF-9	"Yes, the explicit relationship between ""FSH"" and ""GDF-9"" in this context is that they can enhance the effect on survival, activation, and growth of cattle primordial follicles when used in combination."
22516229	FSH	bFGF	"Yes, there is an explicit relationship between ""FSH"" and ""bFGF"" in this context as they are combined and investigated for their effects on survival, activation, and growth of cattle primordial follicles. Similarly, there is a relationship between ""FSH"" and ""GDF-9"" for the same purpose. These combinations result in varying degrees of improvement compared to FSH medium alone."
22516229	GDF-9	bFGF	"Yes, in context, GDF-9 and bFGF enhance the effect of FSH on the survival, activation, and growth of cattle primordial follicles when used in combination with FSH in an in vitro culture."
26525587	TLR9	S100A8	"Yes, there is an explicit relationship between ""TLR9"" and ""S100A8"" as the increased expression of TLR9 is associated with the pro-inflammatory S100A8 and IL-8 in diabetic wounds. This implies that TLR9 activation may lead to the release of S100A8 as a result of its involvement in innate immune regulation."
26525587	TLR9	IL-8	"Yes, there is an explicit relationship between TLR9 and IL-8 described in the context, as TLR9 activation induces the release of the pro-inflammatory molecule IL-8 by myeloid cells."
26525587	S100A8	IL-8	"Yes, there is an explicit relationship between ""S100A8"" and ""IL-8"" in this context as they are presented as downstream effector molecules of TLR9 that are increased in diabetic wounds and may contribute to impaired wound healing in T2DM patients."
26812075	FXR	NR0B2	"Yes (In the given context, FXR target genes such as NR0B2 are regulated by OCA in human precision cut liver slices, indicating an explicit relationship between FXR and NR0B2.)"
26812075	FXR	ABCB11	"Yes, ABCB11 is mentioned as a well-known FXR target gene regulated by OCA (obeticholic acid) in human precision cut liver slices (hPCLS), indicating an explicit relationship between ""FXR"" and ""ABCB11""."
26812075	FXR	SLC51A	"Yes, there is an explicit relationship between ""FXR"" and ""SLC51A"" as SLC51A (OSTβ) is mentioned as one of the well-known FXR target genes regulated by OCA in human precision cut liver slices (hPCLS) in the given context. Similarly, SLC51B (OSTα) is also listed as an FXR target gene."
26812075	FXR	SLC51B	"Yes, there is an explicit relationship between ""FXR"" and SLC51A (OSTα) and SLC51B (OSTβ) mentioned in the context, as these genes are the regulated targets by OCA (Obeticholic acid) in human precision cut liver slices."
26812075	FXR	ABCB4	Yes (ABCB4 is identified as a regulated gene by OCA in hPCLS and as a potential FXR target.)
26812075	FXR	AKAP13	"No, there is no explicit relationship between ""FXR"" and ""AKAP13"" for the subject of interest (AKAP13's direct relationship with FXR) discussed in the given context. FXR binding to IR1 sequences of AKAP13 is mentioned in a separate context of ""ChIP-sequencing in mouse liver"", but this does not directly imply an explicit relationship between FXR and AKAP13 in human liver slices or the context of OCA treatment."
26812075	FXR	CGNL1	"Yes, to determine if the context provides an explicit relationship between ""FXR"" and ""CGNL1"", we need to focus on the information regarding these two specific genes. In this case, while the text explains the identification of six novel bona-fide FXR target genes in both mouse and human liver, it directly mentions the confirmation of FXR binding to IR1 sequences of AKAP13, CGNL1, DYRK3, PDIA5, PPP1R3B, and TBX6. So, this context establishes an explicit relationship between FXR and CGNL1 by indicating that FXR binds to the IR1 sequence of CGNL1. Thus, my answer is ""yes""."
26812075	FXR	DYRK3	"No, there is no explicit direct relationship between FXR and DYRK3 mentioned within this context, although FXR binding to the IR1 sequences of DYRK3 was confirmed through ChIP-sequencing in mouse liver."
26812075	FXR	PDIA5	"Yes, to answer the given question, we need to find any explicit relationship between ""FXR"" and ""PDIA5"" in the provided context. We find that ingenuity pathway analysis confirmed the change in a pathway upon OCA treatment, and FXR binding to the IR1 sequence of PDIA5 is confirmed by ChIP-sequencing in mouse liver. This indicates that there is an explicit relationship between FXR and PDIA5. Therefore, the answer is ""yes""."
26812075	FXR	PPP1R3B	"Yes, based on the given context, the relationship between ""FXR"" and ""PPP1R3B"" is that FXR binding is confirmed to the IR1 (initiator region 1) sequences of PPP1R3B in mouse liver through ChIP-sequencing. So, the answer is ""yes""."
26812075	FXR	TBX6	"Yes, to answer this question, I looked for any direct relationship mentioned between FXR and TBX6 in the given context. The text mentions that ""ChIP-sequencing in mouse liver confirmed FXR binding to IR1 sequences of AKAP13, CGNL1, DYRK3, PDIA5, PPP1R3B and TBX6."" This explains that FXR binds to the IR1 sequence of TBX6 in mouse liver, which implies an explicit relationship between ""FXR"" and ""TBX6"". Therefore, the answer is ""yes""."
26812075	NR0B2	ABCB11	"Yes, NR0B2 (SHP) and ABCB11 (BSEP) have an explicit relationship with each other because they are both ""well-known FXR target genes"" that are regulated by OCA (obeticholic acid) in human precision cut liver slices (hPCLS). This makes it evident that both genes are connected in reference to the specific Farnesoid X receptor (FXR) mechanism within this given context."
26812075	NR0B2	SLC51A	"No, to answer the question, we need to identify if there is any mention of an explicit relationship between NR0B2 (SHP) and SLC51A (OSTβ). The context provided shows both NR0B2 and SLC51A to be regulated by OCA in human precision cut liver slices (hPCLS) and identified as potential FXR targets. However, it doesn't explicitly describe any direct relationship between these two genes other than both being regulated by OCA and linked to FXR. Answer: No"
26812075	NR0B2	SLC51B	"No, the given context explicitly relates ""NR0B2 (SHP)"" to FXR as a well-known target gene and also mentions ""SLC51A (OSTβ)"" and ""SLC51B (OSTα)"" as target genes regulated by OCA in hPCLS, indicating an explicit relationship between them and FXR. However, it does not provide a direct relationship between just ""NR0B2"" and ""SLC51B"" in this context. Therefore, with the information given, the answer is ""no"" for an explicit relationship between ""NR0B2"" and ""SLC51B""."
26812075	NR0B2	ABCB4	"Yes, to address the given context, the explicit relationship mentioned between NR0B2 (SHP) and ABCB4 (MDR3) is that they are both regulated by obeticholic acid (OCA), a known agonist for the Farnesoid X receptor (FXR), in hPCLS (human precision cut liver slices). This makes their expression patterns related through their common regulator, OCA/FXR. Therefore, the answer is ""yes""."
26812075	NR0B2	AKAP13	"No, there is no explicit relationship between ""NR0B2"" and ""AKAP13"" mentioned in the context."
26812075	NR0B2	CGNL1	"No, there is no explicit relationship mentioned between ""NR0B2"" and ""CGNL1"" in the given context."
26812075	NR0B2	DYRK3	"No, there is no explicit direct relationship between ""NR0B2"" and ""DYRK3"" demonstrated in this context. However, they are both part of the identified set of potential FXR targets."
26812075	NR0B2	PDIA5	"No, there is no explicit relationship between ""NR0B2"" and ""PDIA5"" stated in the given context. Both are mentioned as potential FXR targets, but there's no direct relationship between the two genes expressed in the text."
26812075	NR0B2	PPP1R3B	"No explicit relationship is described between ""NR0B2"" and ""PPP1R3B"" in this context."
26812075	NR0B2	TBX6	"No, there is no explicit relationship mentioned between ""NR0B2"" and ""TBX6"" in this context. Both genes are listed as potential FXR targets though."
26812075	ABCB11	SLC51A	"No, there is no explicit direct relationship mentioned between ""ABCB11"" and ""SLC51A"" in the provided context. Both are mentioned as well-known FXR targets, but there's no direct relationship described between them."
26812075	ABCB11	SLC51B	"No (there is no explicit relationship stated between ""ABCB11"" and ""SLC51B"" in the given context)"
26812075	ABCB11	ABCB4	Yes (ABCB11 and ABCB4 are both regulated by OCA in hPCLS and identified as potential FXR targets in both mouse and human liver.)
26812075	ABCB11	AKAP13	"No, there is no explicit relationship between ""ABCB11"" and ""AKAP13"" presented in this context."
26812075	ABCB11	CGNL1	"No, there is no explicit relationship mentioned between ""ABCB11"" and ""CGNL1"" in the given context."
26812075	ABCB11	DYRK3	"No, there is no explicit relationship between ""ABCB11"" and ""DYRK3"" described in this context. Both genes are listed among the potential FXR targets identified in mouse and human livers, but no specific relationship between them is mentioned."
26812075	ABCB11	PDIA5	"No, there is no explicit relationship described between ""ABCB11"" and ""PDIA5"" in the given context. They are both listed as potential FXR targets."
26812075	ABCB11	PPP1R3B	"No, there is no explicit relationship between ""ABCB11"" and ""PPP1R3B"" mentioned in this context."
26812075	ABCB11	TBX6	"No, the explicit relationship between ""ABCB11"" and ""TBX6"" is not mentioned in the given text. They are both separately identified as potential FXR targets in either human or mouse livers but there is no explicit connection stated between these two genes."
26812075	SLC51A	SLC51B	"No, there isn't an explicitly stated relationship between ""SLC51A"" and ""SLC51B"" in the given context. Both are listed as FXR target genes, but a relationship between them isn't mentioned."
26812075	SLC51A	ABCB4	"No, there isn't an explicitly mentioned direct relationship between ""SLC51A"" and ""ABCB4"" in this context. They are both mentioned as potential FXR targets."
26812075	SLC51A	AKAP13	"No, there is no explicit relationship between ""SLC51A"" and ""AKAP13"" mentioned in this context. The context mainly discusses the response to FXR agonist obeticholic acid (OCA) on gene expression. It mentions SLC51A, related to bile acid regulations, and AKAP13 as novel FXR target genes identified in both mouse and human livers. However, the relationship between these two genes is not specifically explained within the provided context."
26812075	SLC51A	CGNL1	"No, the explicit relationship between ""SLC51A"" and ""CGNL1"" is not described in the given context."
26812075	SLC51A	DYRK3	"No, there is no explicit relationship between ""SLC51A"" and ""DYRK3"" presented in the context."
26812075	SLC51A	PDIA5	"No, the explicit relationship between ""SLC51A"" and ""PDIA5"" is not mentioned in the provided context. Both genes are mentioned as potential FXR targets identified via gene expression profiling; however, there is no direct link stated between them."
26812075	SLC51A	PPP1R3B	"No, there is no explicit relationship between ""SLC51A"" and ""PPP1R3B"" described in this context."
26812075	SLC51A	TBX6	"No, there is no explicit direct relationship between ""SLC51A"" and ""TBX6"" described in this context. They are both listed as potential FXR targets identified through gene expression profiles."
26812075	SLC51B	ABCB4	"No, there is no explicit direct relationship between ""SLC51B"" and ""ABCB4"" described or implied within this context. Both genes are mentioned as potential FXR targets in response to treatment but no specific relationship is stated."
26812075	SLC51B	AKAP13	"No, there is no explicit relationship between ""SLC51B"" and ""AKAP13"" described in the given context."
26812075	SLC51B	CGNL1	"No, an explicit relationship between ""SLC51B"" and ""CGNL1"" is not mentioned in the given context."
26812075	SLC51B	DYRK3	"No, there is no explicit relationship described between ""SLC51B"" and ""DYRK3"" in this context. They are both identified as potential FXR targets in separate sentences."
26812075	SLC51B	PDIA5	"No, there isn't an explicitly described relationship between ""SLC51B"" and ""PDIA5"" in the provided context. Both are mentioned as potential FXR targets discovered through the study, but a specific relationship between these two genes is not provided."
26812075	SLC51B	PPP1R3B	"No, there is no explicit relationship between ""SLC51B"" and ""PPP1R3B"" mentioned in the given context."
26812075	SLC51B	TBX6	"No, there is no explicit direct relationship between ""SLC51B"" and ""TBX6"" described in the given context. Both genes are listed as potential FXR targets identified in both mouse and human liver, but no specific relationship is mentioned between them."
26812075	ABCB4	AKAP13	"No, there is no explicit direct relationship between ""ABCB4"" and ""AKAP13"" described in this context. Both genes are mentioned as potential FXR targets, but they are not directly linked in any specific way."
26812075	ABCB4	CGNL1	"No, there is no explicit relationship described between ""ABCB4"" and ""CGNL1"" in this context. ABCB4 is related to FXR as a target gene, while CGNL1 is mentioned as one of the potential FXR targets identified with FXR binding to its IR1 sequence in mouse liver. However, no direct relationship between these two genes has been explicitly established in the given context."
26812075	ABCB4	DYRK3	"No, there isn't an explicit direct relationship between ""ABCB4"" and ""DYRK3"" described in the given context. However, they are both mentioned as potential FXR targets."
26812075	ABCB4	PDIA5	"No, there is no explicit relationship between ""ABCB4"" and ""PDIA5"" mentioned in this context. Both are listed as potentially regulated genes by OCA that activates FXR, but no specific relationship between them is given."
26812075	ABCB4	PPP1R3B	"No, there is no explicit relationship stated between ""ABCB4"" and ""PPP1R3B"" in this context. Both are mentioned as potential FXR targets, but a direct connection between them is not provided."
26812075	ABCB4	TBX6	"No, the explicit relationship between ""ABCB4"" and ""TBX6"" is not described in the given context. They are only mentioned as differentially expressed genes potentially regulated by FXR in human liver and mouse livers."
26812075	AKAP13	CGNL1	"No, there is no explicit relationship between ""AKAP13"" and ""CGNL1"" described in the context provided. The context highlights the discovery of six novel FXR target genes in both mouse and human liver, which include AKAP13, CGNL1, DYRK3, PDIA5, PPP1R3B, and TBX6. However, it doesn't provide any explicit relationship between AKAP13 and CGNL1."
26812075	AKAP13	DYRK3	"No, there isn't an explicit direct relationship between AKAP13 and DYRK3 mentioned in the given context. However, both genes are among the six newly identified bona-fide FXR target genes in both mouse and human livers."
26812075	AKAP13	PDIA5	"No, there is no explicit direct relationship mentioned between ""AKAP13"" and ""PDIA5"" within this context. They are only described as genes with FXR binding to their IR1 sequences in ChIP-sequencing in mouse liver."
26812075	AKAP13	PPP1R3B	"No, there is no explicit direct relationship mentioned between AKAP13 and PPP1R3B in this context. Both genes are identified as potential FXR targets in both mouse and human liver."
26812075	AKAP13	TBX6	"Yes, there is an explicit relationship between ""AKAP13"" and ""TBX6"" as both genes are identified as common potential FXR targets and ChIP-sequencing in mouse liver confirmed FXR binding to IR1 sequences of AKAP13 and TBX6."
26812075	CGNL1	DYRK3	"No, to answer this task, I have analyzed the given context for any explicit relationships mentioned between the genes CGNL1 and DYRK3. While the text does mention FXR binding to IR1 sequences of AKAP13, CGNL1, DYRK3, PDIA5, PPP1R3B, and TBX6, it does not explicitly provide a relationship between CGNL1 and DYRK3. Therefore, based on the provided context, the answer is ""no""."
26812075	CGNL1	PDIA5	"No, there is no explicit relationship between ""CGNL1"" and ""PDIA5"" mentioned in the given context. The text discusses FXR target genes and its binding to IR1 sequences of several genes, which includes AKAP13, CGNL1, DYRK3, PDIA5, PPP1R3B, and TBX6. However, it does not provide a direct explicit relationship between CGNL1 and PDIA5."
26812075	CGNL1	PPP1R3B	"No, the explicit relationship between ""CGNL1"" and ""PPP1R3B"" is not mentioned in this context. Both are mentioned as potential FXR targets sharing FXR binding to IR1 sequences in mouse liver."
26812075	CGNL1	TBX6	"No, while the text mentions CGNL1 and TBX6 as potential FXR targets identified by ChIP-sequencing in mouse liver, there isn't any explicit relationship mentioned between CGNL1 and TBX6 within this context. The focus is on their relationship with FXR."
26812075	DYRK3	PDIA5	"No, based on the given context, the explicit relationship between ""DYRK3"" and ""PDIA5"" is that both are potential FXR targets with FXR binding to IR1 sequences of these genes according to ChIP-sequencing in mouse liver. However, this information pertains solely to their relationship concerning FXR and not between themselves."
26812075	DYRK3	PPP1R3B	"No, there is no explicit relationship between ""DYRK3"" and ""PPP1R3B"" described in the given context. Both genes are mentioned among the potential FXR targets, but no specific relationship between them is stated or implied."
26812075	DYRK3	TBX6	"Yes, there is an explicit relationship between ""DYRK3"" and ""TBX6"" with FXR, as both genes were among the 18 common potential FXR targets identified and FXR binding to IR1 sequences of DYRK3 and TBX6 was confirmed via ChIP-sequencing in mouse liver."
26812075	PDIA5	PPP1R3B	No (there is no explicit relationship mentioned between PDIA5 and PPP1R3B in this context)
26812075	PDIA5	TBX6	"No, in the given context, there is an explicit relationship between ""PDIA5"" and ""FXR"" because FXR binding to an IR1 sequence of PDIA5 is confirmed through ChIP-sequencing in mouse liver. However, no explicit relationship between PDIA5 and TBX6 is mentioned. Similarly, there's an explicit relationship between ""TBX6"" and ""FXR"" because FXR binding to an IR1 sequence of TBX6 is also confirmed through ChIP-sequencing in mouse liver. But it is important to note that the relationship between PDIA5 and TBX6 is not explicitly discussed. So, the answer is a ""no"" for the relationship between PDIA5 and TBX6 in this context."
26812075	PPP1R3B	TBX6	"No, there is no explicit direct relationship between ""PPP1R3B"" and ""TBX6"" described in this context. Both genes are mentioned as some of the six new putative FXR target genes identified in both mouse and human liver."
27100621	Akh	AHR	"No, there is no explicit direct relationship established between ""Akh"" and ""AHR"" in the given context."
27100621	Akh	NR1I2	"No, the text does not explicitly establish a direct relationship between ""Akh"" and ""NR1I2"" in terms of interaction, regulation, or influence. It does show that chronic Dibutyl Phthalate (DBP) exposure affects Akh expression and that the expression of genes including NR1I2 (Hr96) is influenced by Akh. However, this does not directly demonstrate a relationship between Akh and NR1I2."
27100621	Akh	ABCB1	"No, while the text discusses the relationship between DBP (dibutyl phthalate) exposure and various phenotypes in Drosophila, as well as the impact on genes like AHR, NR1I2, ABCB1, ABCC3, and CYP3A4, there is no direct and explicit relationship described between ""Akh"" (adipokinetic hormone) and ""ABCB1"" (MDR50 in Drosophila) in this context."
27100621	Akh	ABCC3	No
27100621	Akh	CYP3A4	"No, there is no explicit direct relationship between ""Akh"" and ""CYP3A4"" described in this context, but both are influenced by the expression of genes that are affected by DBP exposure."
27100621	AHR	NR1I2	"No, in this context, there is a direct relationship mentioned between ""AHR"" (in Drosophila, specifically ""ss"") and its human homolog ""NR1I2"" (referred to as ""Hr96"" in Drosophila), as both genes are implicated in xenobiotic and lipid metabolism and are affected by DBP exposure. Additionally, the expression of these genes is influenced by Akh (Drosophila's glucagon analogue)."
27100621	AHR	ABCB1	"Yes, there is an explicit relationship between ""AHR"" (Aryl hydrocarbon receptor which is Drosophila AHR in this context) and ""ABCB1"" (Multidrug resistance protein 1 which is Drosophila MDR50 in this context) because both genes are found to be influenced by DBP exposure and by Akh (Adipokinetic hormone) in the flies, according to the results presented in this context."
27100621	AHR	ABCC3	"No, to answer this question, I'll identify and analyze the connections between AHR and ABCC3 in the provided text: - The text indicates that genes involved in xenobiotic and lipid metabolism are affected by DBP, including AHR (Drosophila ss), NR1I2 (Hr96), ABCB1 (MDR50), ABCC3 (MRP), and CYP3A4 (Cyp9f2). - The expression of these genes, including AHR and ABCC3, is shown to be affected by Akh (adipokinetic hormone). Based on these details, there is a relationship between AHR and ABCC3, as both are influenced in terms of expression by phthalate exposure. However, it is important to clarify that the explicit relationship between AHR and ABCC3, as specified in the text, is related to their shared regulation under phthalate (DBP) exposure and the conserved insulin- and glucagon-like signaling."
27100621	AHR	CYP3A4	"Yes, there is an explicit relationship between ""AHR"" (Drosophila ss) and the genes involving xenobiotic and lipid metabolism, including ""CYP3A4"" (Cyp9f2), as their expression is affected by DBP or its feeding in the context provided."
27100621	NR1I2	ABCB1	"Yes, there is an explicit relationship between ""NR1I2"" and ""ABCB1"" in this context, as both are mentioned as homologous genes involved in xenobiotic and lipid metabolism that are affected by DBP exposure."
27100621	NR1I2	ABCC3	"Yes, there is an explicit relationship between ""NR1I2"" (Hr96 homologue in Drosophila) and ""ABCC3"" (MRP in Drosophila) mentioned in the given context. Both genes are affected by DBP food feeding and are involved in xenobiotic and lipid metabolism. Furthermore, the expression of these genes is influenced by the glucagon analogue Akh."
27100621	NR1I2	CYP3A4	"Yes (There is an explicit relationship between ""NR1I2"" and ""CYP3A4"" as both are mentioned as homologous genes involved in xenobiotic and lipid metabolism that are affected by DBP exposure.)"
27100621	ABCB1	ABCC3	"Yes, there is an explicit relationship between ""ABCB1"" and ""ABCC3"" in this context as they are both mentioned as being involved in xenobiotic and lipid metabolism genes affected by dibutyl phthalate (DBP) exposure in Drosophila males."
27100621	ABCB1	CYP3A4	"Yes, there is an explicit relationship between ""ABCB1"" and ""CYP3A4"" in this context as both are mentioned to be affected by DBP (dibutyl phthalate) exposure and involved in genes responsible for xenobiotic and lipid metabolism. Additionally, their expression is influenced by Akh (adipokinetic hormone, a glucagon analogue)."
27100621	ABCC3	CYP3A4	"Yes, there is an explicit relationship between ""ABCC3"" and ""CYP3A4"" mentioned in the context, as it states that the expression of these genes involved in xenobiotic and lipid metabolism (AHR, NR1I2, ABCB1, ABCC3, and CYP3A4) is affected by DBP food."
27551309	TCF7L2	HHEX	"Yes, based on the given context, there is an explicit relationship between ""TCF7L2"" and ""HHEX"" as they are both mentioned as part of the 7 genes (9 SNPs) annotated for involvement in WNT signaling. However, it is essential to note that the text does not explicitly mention an interactive relationship between TCF7L2 and HHEX with dietary fiber on type 2 diabetes incidence. Their involvement is individually introduced with the WNT signaling pathway."
27551309	TCF7L2	HNF1A	"Yes, there is an explicit relationship between ""TCF7L2"" and ""HNF1A"" in this context, as they are both included among the seven genes involved in WNT signaling that were analyzed for their potential links to type 2 diabetes."
27551309	TCF7L2	NOTCH2	"Yes, there is an explicit relationship between ""TCF7L2"" and ""NOTCH2"" as they were both found to show significant interactions with fiber intake on type 2 diabetes incidence."
27551309	TCF7L2	TLE4	"Yes, the text explicitly describes an explicit relationship between ""TCF7L2"" and the involvement in the WNT signaling pathway, and it also shows an interaction between TCF7L2 variants and dietary fiber on type 2 diabetes risk. Moreover, there is a mentioned relationship between TCF7L2 and other genes such as HHEX, HNF1A, NOTCH2, TLE4, ZBED3, and PPARG, as they are all annotated as involved in WNT signaling. However, the text does not provide a specific relationship between TCF7L2 and TLE4 other than both being part of the WNT signaling pathway."
27551309	TCF7L2	PPARG	"Yes, there is an explicit relationship between ""TCF7L2"" and the ""dietary fiber intake"" mentioned in the context as the genetic variants in TCF7L2 interact with dietary fiber intake on type 2 diabetes risk. Although the context provides relationships for TCF7L2 and other genes as well, there is no direct explicit relationship mentioned between TCF7L2 and PPARG in this passage."
27551309	TCF7L2	ZBED3	"Yes, there is an explicit relationship between ""TCF7L2"" and ""ZBED3"" as both genes were shown to display significant interactions with fiber intake on type 2 diabetes incidence according to the given context."
27551309	HHEX	HNF1A	"Yes (specifically, HHEX and HNF1A are mentioned as genes annotated as involved in WNT signaling, although the text does not mention any explicit interactions between HHEX and HNF1A regarding fiber intake or type 2 diabetes incidence)."
27551309	HHEX	NOTCH2	"Yes, there is an explicit relationship between ""HHEX"" and ""NOTCH2"" in this context because both genes (along with six others) are annotated to be involved in the WNT signaling pathway and are included in the genetic variants analyzed. Additionally, a significant interaction between the SNPs in NOTCH2 and ZBED3 with fiber intake on type 2 diabetes incidence is mentioned in the results."
27551309	HHEX	TLE4	"Yes, the text establishes an explicit relationship between ""HHEX"" and ""TLE4"" as both genes (along with other genes) are involved in WNT signaling and annotated in the study. Additionally, their respective SNPs (rs1111875 for HHEX and rs13292136 for TLE4) are mentioned within the context of the study."
27551309	HHEX	PPARG	"Yes, there is an explicit relationship between ""HHEX"" and ""PPARG"" mentioned in this context as both genes are among the seven genes identified that are annotated as involved in WNT signaling. However, it is important to note that the provided text does not specifically establish any interaction between HHEX and PPARG with dietary fiber on type 2 diabetes incidence."
27551309	HHEX	ZBED3	"Yes, the text explicitly mentions significant interactions between SNPs in TCF7L2, NOTCH2, and ZBED3 and fiber intake on type 2 diabetes incidence."
27551309	HNF1A	NOTCH2	"Yes, there is an explicit relationship between ""HNF1A"" and ""NOTCH2"" in this context as they are both mentioned as some of the seven genes involved in the WNT signaling pathway. Additionally, both genes have their specific SNPs that show significant interactions with fiber intake on type 2 diabetes incidence."
27551309	HNF1A	TLE4	"Yes, there are explicit relationships mentioned between two genes in this context, specifically ""TCF7L2"" and ""TLE4"" as part of the 26,905 individuals without diabetes from the Malmö Diet and Cancer Study cohort. Both genes are involved in WNT signaling and have relevant single nucleotide polymorphisms (SNPs) associated with them. Additionally, ""TCF7L2"", ""NOTCH2"", and ""ZBED3"" show significant interactions with fiber intake on type 2 diabetes incidence. However, ""HNF1A"" doesn't seem to have such an explicit relationship with ""TLE4"" within this provided context."
27551309	HNF1A	PPARG	"Yes, there is an explicit relationship between ""HNF1A"" and ""PPARG"" in this context, as both are included among the seven genes (nine single nucleotide polymorphisms (SNPs)) annotated as involved in the WNT signaling pathway. However, we should note that the text does not specifically mention any interaction between HNF1A and PPARG, only their association with WNT signaling genes and type 2 diabetes."
27551309	HNF1A	ZBED3	"Yes, in this context, there is an explicit relationship between ""HNF1A"" (specifically the SNP rs7957197) and ""ZBED3"" (specifically the SNP rs4457053) as they are both identified as gene loci that were analyzed for their involvement in WNT signaling and showed significant interactions with fiber intake on type 2 diabetes incidence. Besides these two mentioned genes, another gene, ""NOTCH2"" (specifically the SNP rs10923931), is also found to have a significant interaction with fiber intake on type 2 diabetes incidence."
27551309	NOTCH2	TLE4	Yes (There is an explicit relationship between NOTCH2 and TLE4 as both are mentioned among the seven genes that were annotated as involved in the WNT signaling pathway.)
27551309	NOTCH2	PPARG	"Yes, this context mentions an explicit relationship between ""NOTCH2"" and type 2 diabetes incidence in relation to dietary fiber intake. Additionally, it also mentions a relationship between ""PPARG"" and type 2 diabetes incidence when considering the analyzed SNPs (rs1801282 and rs13081389). However, it doesn't describe a direct relationship between NOTCH2 and PPARG."
27551309	NOTCH2	ZBED3	"No, to answer this question, we need to determine if there is any relationship mentioned between NOTCH2 and ZBED3 in this context. Both these genes are mentioned as having significant interactions with fiber intake on type 2 diabetes incidence. However, this information does not explicitly show a relationship between NOTCH2 and ZBED3 themselves. Therefore, my answer is ""no"" based on the given context."
27551309	TLE4	PPARG	"Yes, based on the given context, there is an explicitly described relationship between ""TLE4"" and ""PPARG"" as both genes are mentioned among the seven genes annotated as involved in WNT signaling. Additionally, interactions between their respective SNPs with fiber intake were found to be significantly linked with type 2 diabetes incidence."
27551309	TLE4	ZBED3	"No, to answer this question, I analyzed the given context to determine if there is a direct relationship mentioned between ""TLE4"" and ""ZBED3."" Although both genes were found to be annotated as involved in the WNT signaling pathway, the text specifically mentions significant interaction between fiber intake and type 2 diabetes incidence for TCF7L2, NOTCH2, and ZBED3 SNPs, but not TLE4. So, based on the provided context, my answer is ""no"" - there is not an explicitly described relationship between TLE4 and ZBED3 regarding fiber intake interaction."
27551309	PPARG	ZBED3	"No, to answer the given question, we need to look for a specific relationship between ""PPARG"" and ""ZBED3"" within this context. We find that both genes are part of the group of seven genes (nine single nucleotide polymorphisms (SNPs)) annotated as involved in WNT signaling. However, the text only explicitly mentioned an interaction between SNPs in TCF7L2, NOTCH2, and ZBED3 with fiber intake on type 2 diabetes incidence. There is no direct mention of an explicit relationship between PPARG and ZBED3 in terms of interaction with fiber intake or other factors. Answer: No"
30445175	IL-6	IL-10	"Yes, there is an explicit relationship between ""IL-6"" and the immunomodulatory effect of the probiotics described in the text, as production of both anti-inflammatory cytokines (IL-6) and pro-inflammatory chemokines was observed. Similarly, there is a relationship between ""IL-10"" and immunomodulation since ""IL-6"" and ""IL-10"" are mentioned together as anti-inflammatory cytokines produced in response to the probiotics."
30445175	IL-6	MCP-1	"Yes, there is an explicit relationship mentioned between ""IL-6"" and the probiotics described in the context. Production of IL-6 (an anti-inflammatory cytokine) was increased as an immunomodulatory effect of the probiotics."
30445175	IL-6	CXCL10	"No, the explicit relationship between ""IL-6"" and ""CXCL10"" mentioned in the given context is that only indicates an increased production of anti-inflammatory cytokine IL-6 and a reduced production of inflammatory chemokines, which include MCP-1, CXCL10, and IL-8."
30445175	IL-6	IL-8	"Yes, there is an explicit relationship between ""IL-6"" and the probiotics described in the text as it is mentioned that the probiotics increased the production of anti-inflammatory cytokine IL-6. However, the relationship between ""IL-6"" and ""IL-8"" is not explicitly described in the given context. Similarly, there's a relationship between ""IL-8"" and the probiotics as the production of the inflammatory chemokine IL-8 is reduced due to the presence of probiotics in the gut model."
30445175	IL-10	MCP-1	"No, in this context, there isn't a direct, explicit relationship described between ""IL-10"" and ""MCP-1"". However, it is mentioned that the probiotics increased production of the anti-inflammatory cytokine IL-10 while reducing production of inflammatory chemokines which include MCP-1."
30445175	IL-10	CXCL10	"Yes (the text describes an immunomodulatory effect of the probiotics that leads to an increase in anti-inflammatory cytokines IL-6 and IL-10, as well as a reduction in inflammatory chemokines such as MCP-1, CXCL10, and IL-8.)"
30445175	IL-10	IL-8	"Yes, there is an explicit relationship between ""IL-10"" and the probiotic effects described in the text as it mentions an increase in production of the anti-inflammatory cytokine IL-10 due to the immunomodulatory effect of the probiotics. Similarly, a relationship between inflammatory chemokines such as IL-8 and probiotics is also mentioned due to a reduction in its production."
30445175	MCP-1	CXCL10	"No, there is no explicit direct relationship mentioned between ""MCP-1"" and ""CXCL10"" in the given context. However, there is a mention of a reduction in production of inflammatory chemokines, which includes both MCP-1 and CXCL10."
30445175	MCP-1	IL-8	"No, to answer the given context, there is no explicit direct relationship explicitly mentioned between MCP-1 and IL-8. However, the text reveals that the four-strain probiotic had an immunomodulatory effect, leading to increased production of anti-inflammatory cytokines (IL-6 and IL-10) and reduced production of inflammatory chemokines (MCP-1, CXCL10, and IL-8)."
30445175	CXCL10	IL-8	"No, in the given context, ""IL-8"" is mentioned as an inflammatory chemokine that is reduced in production due to the immunomodulatory effect of the probiotics. However, no explicit relationship between ""CXCL10"" and ""IL-8"" is described. Therefore, the answer is ""no""."
30446510	FLCN	PAT1	"Yes, there is an explicit relationship between FLCN and PAT1 in this context. FLCN can inhibit the binding of overexpressed PAT1 to the lysosome in human embryonic kidney 293 cells, impacting lysosomal amino acid pools and mTORC1 signaling pathway activation. Both proteins are shown to be linked through their interaction with Rab11A in the Rab11A-mediated recycling transport pathway. The suppression of either Rab11A or FLCN results in overexpressed PAT1 localization to the lysosome and inhibition of plasma membrane targeting, leading to down-regulation of mTORC1."
30446510	FLCN	Rab11A	"Yes, there is an explicit relationship between ""FLCN"" and ""Rab11A"" as FLCN can bind to the recycling transport regulator Rab11A through its C-terminal DENN-like domain. Additionally, FLCN promotes the loading of PAT1 on Rab11A in the Rab11A-mediated recycling pathway."
30446510	PAT1	Rab11A	"Yes, there is an explicit relationship between ""PAT1"" and ""Rab11A"" as they both participate in the recycling transport process regulated by Rab11A, and the localization of PAT1 can be affected by modulating either Rab11A or the protein FLCN that directly binds to Rab11A through its C-terminal DENN-like domain."
30446621	MCT1	MCT2	"Yes, there is an explicit relationship mentioned between MCT1 and MCT4 (as MCTs) and carbonic anhydrase IV (CAIV) since the transport activity of MCT1, MCT2, and MCT4 can be facilitated by CAIV via a noncatalytic mechanism. The explicit relationship between MCT2 and CAIV is established through this facilitation mechanism as MCT2 is one of the MCTs involved in this interaction. However, the text does not specifically discuss interactions between MCT1 and MCT2 or any relationship between them other than both being part of the monocarboxylate transporters (MCTs)."
30446621	MCT1	MCT4	"Yes, there is an explicit relationship between ""MCT1"" and ""MCT4"" in this context. They are mentioned as members of the monocarboxylate transporters (MCTs) family whose transport activity can be facilitated by extracellular carbonic anhydrase IV (CAIV)."
30446621	MCT1	CAIV	"Yes, there is an explicit relationship between ""MCT1"" and ""CAIV"" described in this context, as CAIV can facilitate the transport activity of MCT1 via a noncatalytic mechanism, with this effect requiring direct binding between CAIV and MCT1's chaperones."
30446621	MCT1	CD147	"Yes, there is an explicit relationship between ""MCT1"" and ""CD147"" as they are both connected via the extracellular carbonic anhydrase IV (CAIV) which binds directly to CD147 (one of the MCT chaperones) to facilitate MCT transport activity, including that of MCT1."
30446621	MCT1	GP70	"Yes (There is an explicit relationship between ""MCT1"", as well as MCT2 and MCT4, and ""GP70"" [which is referred to as embigin in the text] through their interaction with the common chaperone proteins CD147 and GP70. This relationship is further established by the direct interaction between carbonic anhydrase IV and the MCT transporter's chaperones, including GP70.)"
30446621	MCT2	MCT4	"Yes (Based on the text, there is a relationship between MCTs like MCT1, MCT2, and MCT4, and carbonic anhydrase IV (CAIV), as CAIV can facilitate their transport activity through a noncatalytic mechanism, involving interactions with their chaperones CD147 and GP70.)"
30446621	MCT2	CAIV	"Yes, there is an explicit relationship between MCT2 and CAIV described in this context, as CAIV can facilitate the transport activity of MCT1, MCT2, and MCT4 through a noncatalytic mechanism and the interaction between CAIV and these MCTs is mediated by their chaperones, CD147 and GP70."
30446621	MCT2	CD147	"Yes, there is an explicit relationship between ""MCT2"" and ""CD147"" as the interaction between membrane-anchored carbonic anhydrase IV (CAIV) with monocarboxylate transporters MCTs involves their chaperones CD147 and GP70. The transport activity of MCT1, MCT2, and MCT4 can be facilitated by CAIV via noncatalytic mechanisms involving the direct binding between CAIV and CD147 as a chaperone of these transporters."
30446621	MCT2	GP70	"Yes, there is an explicit relationship between ""MCT2"" and ""GP70"" in this context as they are both part of a larger system involving monocarboxylate transporters (MCTs) which are chaperoned by CD147 and GP70. CAIV (carbonic anhydrase IV) can interact with MCT1, MCT2, and MCT4, and this interaction occurs via a non-catalytic mechanism involving the direct binding of CAIV to the transporter chaperones, including GP70."
30446621	MCT4	CAIV	"Yes, there is an explicit relationship between ""MCT4"" and ""CAIV"" as the text mentions that the transport activity of MCT1, MCT2, and MCT4 can be facilitated by extracellular carbonic anhydrase IV (CAIV) via a noncatalytic mechanism. This facilitation requires direct binding of CAIV to the transporters' chaperones, which is mediated by a specific residue in both CAIV and the chaperone."
30446621	MCT4	CD147	"Yes, there is an explicit relationship between ""MCT4"" and ""CD147"" established through their association with the chaperone proteins CD147 (also known as basigin) and GP70 (also known as embigin). These chaperones interact with monocarboxylate transporters like MCT4, and their transport activity can be facilitated by the noncatalytic interaction with membrane-anchored carbonic anhydrase IV (CAIV) which directly binds CD147 and GP70 chaperone proteins."
30446621	MCT4	GP70	"Yes, there is an explicit relationship between MCT4 and GP70, as both are components of a system involving monocarboxylate transporters (MCTs), carbonic anhydrases (CA), and their chaperones, CD147 and GP70. The direct interaction between CA and MCT chaperones affects the MCT transport activity, including MCT4."
30446621	CAIV	CD147	"Yes, there is an explicit relationship between ""CAIV"" (carbonic anhydrase IV) and ""CD147"" (basigin) as they directly interact with each other through the highly conserved His-88 residue in CAIV and the negatively charged Glu-73 in human CD147 or positively charged Lys-73 in rat CD147, which contributes to the facilitation of MCT (monocarboxylate transporters) transport activity."
30446621	CAIV	GP70	"Yes, there is an explicit relationship between ""CAIV"" (carbonic anhydrase IV) and ""GP70"" (embigin), as CAIV directly interacts with GP70 and CD147 (basigin), which are the two MCT (monocarboxylate transporters) chaperones. These interactions play a role in facilitating MCT transport activity."
30446621	CD147	GP70	Yes (The explicit relationship is described as CAIV directly binding to the chaperones CD147 and GP70.)
30446626	SETDB1	DPPA2	"Yes, there is an explicit relationship presented between SETDB1 and DPPA2, as altered expression of DPPA2 in the context of SETDB1 depletion affects BMP4 signaling-related genes and plays a part in the PGC (primordial germ cell) determination process. Similarly, relationships are also shown between SETDB1 and other genes such as OTX2 and UTF1."
30446626	SETDB1	OTX2	"Yes, there is a relationship mentioned between SETDB1 and OTX2 in this context. SETDB1 regulates the expression of OTX2 during the fate determination of primordial germ cells. When SETDB1 is knocked down, OTX2 is de-repressed, which may lead to the repression of BMP4 signaling-related genes."
30446626	SETDB1	UTF1	"Yes, un the given context, there is an explicit relationship between SETDB1 and UTF1 because the text mentions that UTF1 (along with DPPA2 and OTX2) is derepressed after knockdown of SETDB1 during PGC-like cell induction. Furthermore, it explains that during PGC determination, overexpression of UTF1, along with DPPA2 and OTX2, leads to the repression of BMP4 signaling-related genes. This suggests a direct connection between SETDB1 and UTF1 in the context of PGC fate determination and regulating BMP (Bone Morphogenic Protein) signaling."
30446626	SETDB1	SMAD1	"No, from the provided context, there is an explicit relationship between ""SETDB1"" and the transcription factors DPPA2 (Dppa2), OTX2 (Otx2), and UTF1 (Utf1), as they affect the expression of BMP signaling-related genes such as SMAD1. However, it is not explicitly mentioned that SETDB1 has a direct relationship with SMAD1 itself, only that its function affects the process of BMP signaling that involves SMAD1."
30446626	DPPA2	OTX2	"No, there is no explicit direct relationship between ""DPPA2"" and ""OTX2"" described in the given context. However, all three genes, ""DPPA2"", ""Otx2"" and ""Utf1"", are involved together in the repression of BMP4 signaling-related genes when overexpressed in cell aggregates containing PGCLCs."
30446626	DPPA2	UTF1	"No, there is no explicit direct relationship described between ""DPPA2"" and ""UTF1"" in this context. However, it is mentioned that the overexpression of all three genes, DPPA2, OTX2, and UTF1, represses BMP4 signaling-related genes and PGC determinant genes in cell aggregates containing PGCLCs. This implies a potential functional interaction among DPPA2, OTX2, and UTF1 but no direct, explicit relationship."
30446626	DPPA2	SMAD1	"Yes, there is an explicit relationship between ""DPPA2"" (also known as Dppa2) and ""SMAD1"" since DPPA2, OTX2, and UTF1 binding is increased in genes encoding BMP4 signaling-related proteins, including SMAD1 in this context."
30446626	OTX2	UTF1	"No, there isn't an explicit direct relationship between ""OTX2"" and ""UTF1"" in this context. They are both mentioned as genes whose expression is affected, potentially through the action of SETDB1, thereby playing a role in PGC determination by ensuring BMP signaling."
30446626	OTX2	SMAD1	"No, while the context mentions a relationship between OTX2 and DPPA2, UTF1, and BMP4 signaling-related genes including SMAD1, it does not explicitly state a direct relationship between OTX2 and SMAD1."
30446626	UTF1	SMAD1	"No, the relationship between ""UTF1"" and ""SMAD1"" in the given context is described as their binding being increased in genes encoding BMP4 signaling-related proteins, including SMAD1. However, this does not represent a direct explicit link between UTF1 and SMAD1."
30450735	TSG101	p53	"Yes, there is an explicit relationship between ""TSG101"" and ""p53"" mentioned in the context as the results showed that knock down of TSG101 significantly decreased the cell cycle related regulatory factor p53."
30450735	TSG101	p21	"Yes, there is an explicit relationship between ""TSG101"" and ""p21"" described in the text. The text states that ""knock down of TSG101 significantly decreased the cell cycle related regulatory factor p53 and p21."" This suggests that TSG101 regulates the expression or activity of p21 in the context of cell cycle regulation."
30450735	TSG101	TIMP1	"No, TIMP1 is mentioned as a factor affected by TSG101 levels, but a direct, explicit relationship between TSG101 and TIMP1 is not explicitly described in the given context. The text focuses on the relationship between TSG101 and PEG10, MMPs, and other factors contributing to HCC development, but not directly with TIMP1."
30450735	TSG101	MMP2	"No, MMP2 is not explicitly described as having a relationship with TSG101 besides being affected by changes in TIMP1 levels."
30450735	TSG101	MMP7	"No, while this context explains the relationship between TSG101 and PEG10, MMP7 is mentioned in the context as being regulated by TSG101 along with MMP2 and MMP9 through TIMP1 (Tissue inhibitors of metalloproteinases 1), but there is no direct explicit relationship mentioned between TSG101 and MMP7."
30450735	TSG101	MMP9	"No, there is no explicit relationship between TSG101 and MMP9 stated to be a direct interaction or regulatory process in this given context. However, TSG101 does affect MMP9 indirectly through the decrease in TIMP1 level."
30450735	TSG101	PEG10	"Yes, there is an explicit relationship between ""TSG101"" and ""PEG10"" described in the context as TSG101 was found to interact with PEG10 and protect it from proteasomal degradation, thereby regulating the expression of p53, p21, and MMPs."
30450735	p53	p21	"Yes, there is an explicit relationship between ""p53"" and ""p21"" in this context as the text mentions that knock down of TSG101 decreases both cell cycle-related regulatory factors, p53 and p21."
30450735	p53	TIMP1	"No, there is no explicit direct relationship between ""p53"" and ""TIMP1"" in this context. The relationship between TSG101 and TIMP1 is mentioned, and both TSG101 and p53 are involved in regulating the cell cycle as it is mentioned that knock down of TSG101 decreased p53 and p21. However, these two proteins aren't directly linked to each other."
30450735	p53	MMP2	"No, in the given context, there is an explicit relationship between ""p53"" and ""TSG101"" as knocking down TSG101 decreases the level of p53. However, there is no explicit relationship described between ""p53"" and ""MMP2"" in this context. There is an explicit relationship between ""MMP2"" and ""TIMP1,"" where TSG101 affects MMP2 through TIMP1. An indirect relationship between TSG101, through PEG10, and MMP2 can also be inferred since TSG101 regulates the level of MMP2, MMP7, and MMP9 through TIMP1. Nonetheless, there is no direct relationship between ""MMP2"" and ""p53"" explicitly mentioned in the text."
30450735	p53	MMP7	"No, in this given context, there is an explicit relationship between ""p53"" and ""TSG101"" as well as ""p21"" and ""TSG101"". There is also an explicit relationship between ""Metallopeptidase inhibitor TIMP1 (Tissue inhibitors of metalloproteinases 1)"", ""MMP2"", ""MMP7"", and ""MMP9"" and ""TSG101"". Among these mentioned proteins, there is an indirect relationship between ""MMP7"" and ""p53"" through their both being influenced by the regulation of ""TSG101"". However, there isn't an explicit direct relationship described between ""p53"" and ""MMP7"". Similarly, although ""TSG101"" influences ""MMP7"", it doesn't seem to have an explicit direct relationship with ""PEG10"". Therefore, the answer for the relationship between ""p53"" and ""MMP7"" is ""no""; for the relationship between ""p53"" and ""PEG10"" is also ""no""; and for the relationship between ""MMP7"" and ""PEG10"" is also ""no""."
30450735	p53	MMP9	"Yes, there is an explicit relationship described between ""p53"" and ""TSG101"" as knocking down TSG101 decreases the level of p53. Additionally, the relationship between TSG101 and MMP9 is through TSG101's effect on the metallopeptidase inhibitor TIMP1, which in turn impacts MMP2, MMP7, and MMP9."
30450735	p53	PEG10	"Yes, TSG101 has an explicit relationship with PEG10, as it interacts with PEG10 and regulates its expression, thereby affecting the expression of other regulatory factors such as p53 and p21."
30450735	p21	TIMP1	"No, there is no explicit relationship mentioned between ""p21"" and ""TIMP1"" in this context. The relationship between TSG101 and p53, p21, and TIMP1 has been explicitly described, but not for p21 and TIMP1."
30450735	p21	MMP2	"No, there is no explicit relationship described between ""p21"" and ""MMP2"" in this context. However, it's mentioned that knocking down TSG101 decreases MMP2, MMP7, and MMP9 due to reduced TIMP1 and increased p53 and p21."
30450735	p21	MMP7	"No, there is no explicit direct relationship established between ""p21"" and ""MMP7"" in this context. ""p21"" is associated with TSG101 and the cell cycle regulation, while MMP7 is associated with TSG101 through the metallopeptidase inhibitor TIMP1."
30450735	p21	MMP9	"No, there is no explicit relationship mentioned between ""p21"" and ""MMP9"" in this context. The relationship described is between the knock down of TSG101 decreasing both p21 and TIMP1 (Tissue inhibitors of metalloproteinases 1), which in turn regulates MMP2, MMP7, and MMP9."
30450735	p21	PEG10	"No, there is no explicit relationship between ""p21"" and ""PEG10"" mentioned in the given context. However, PEG10 is described as a potential downstream target of TSG101, and the text explains that TSG101 affects the expression of factors such as p53 and p21."
30450735	TIMP1	MMP2	"Yes (In the given context, there is a relationship between TSG101 and TIMP1, as knocking down TSG101 results in decreased TIMP1 levels, which leads to the inhibition of MMP2, MMP7, and MMP9. MMP2 is one of these affected MMPs.)"
30450735	TIMP1	MMP7	"Yes, there is an explicit relationship between ""TIMP1"" and ""MMP7"" in the given context. Knocking down TSG101 decreases the level of TIMP1, resulting in inhibition of MMP2, MMP7, and MMP9."
30450735	TIMP1	MMP9	"Yes, there is an explicit relationship between ""TIMP1"" and ""MMP9"" in this context because the text states that ""knock down of TSG101 also obviously decreased the level of metallopeptidase inhibitor TIMP1, which results in inhibition of MMP2, MMP7 and MMP9."""
30450735	TIMP1	PEG10	"No, there is no explicit relationship described between ""TIMP1"" and ""PEG10"" in this context. TIMP1 is related to the regulation of MMPs (metalloproteinases) by TSG101, while PEG10 is suggested as a direct downstream target of TSG101 for the regulation of other factors such as p53, p21, and MMPs."
30450735	MMP2	MMP7	"No, there is no explicit relationship described between ""MMP2"" and ""MMP7"" in this context, only that their expression levels may be regulated by changes in TIMP1 and potentially impacted through TSG101's interaction with PEG10."
30450735	MMP2	MMP9	"No, there is no explicit direct relationship mentioned between ""MMP2"" and ""MMP9"" in the given context. Both are mentioned in the decrease in TIMP1 levels, but they are not connected directly with each other."
30450735	MMP2	PEG10	"Yes, in this context, there is an explicit relationship between ""TSG101"" and ""PEG10"", where TSG101 interacts with PEG10 and prevents its proteasomal degradation, which in turn affects the expression of other factors related to HCC cell proliferation, migration, and invasion. This relationship does not include MMP2."
30450735	MMP7	MMP9	"No, in this given context, there isn't an explicit direct relationship between ""MMP7"" and ""MMP9"" explicitly described. However, it mentions that knock down of TSG101 decreased the level of metallopeptidase inhibitor TIMP1, resulting in the inhibition of MMP2, MMP7, and MMP9, revealing their interconnectedness through TIMP1."
30450735	MMP7	PEG10	Yes (MMP7 is mentioned to be affected through TSG101's interaction with PEG10)
30450735	MMP9	PEG10	"Yes, there is an explicit relationship between ""MMP9"" and ""PEG10"" mentioned in the context as TSG101 affects the level of TIMP1, which in turn influences MMP2, MMP7, and MMP9, and TSG101 interacts with PEG10."
30452920	ATF4	DEFA1	"No, ""DEFA1"" is not explicitly and directly related to ""ATF4"" within this provided context. However, a relationship is established through the fact that ""Atf4&#x394;IEC mice"" (mice with disruption of Atf4 specifically in intestinal epithelial cells) had decreased DEFA1 (also known as human defensin &#x3b1;1) in ileal Paneth cells, and injections of DEFA1 reduced the severity of spontaneous enteritis and colitis in these mice. This relationship is indirect but evident in terms of how the ATF4 deficiency affects the expression of antimicrobial peptides."
30452920	ATF4	DEFA4	"No, there is no explicit relationship described between ""ATF4"" and ""DEFA4"" in the given context. However, there is a relationship mentioned where DEFA4, along with other antimicrobial peptides, is reduced in Atf4-deficient mice due to the role of ATF4 in regulating their expression."
30452920	ATF4	DEFA5	"No, based on the provided context, there is no explicit relationship between ATF4 and DEFA5 besides that they are both involved in inflammatory response and levels of DEFA5 are reduced in Atf4-deficient mice. However, ATF4 indirectly affects DEFA5 by regulating SLC1A5, which controls the uptake of glutamine and the expression of antimicrobial peptides including DEFA5. So the answer is ""no"" for a direct explicit relationship and ""indirect"" for an indirect explicit relationship in this context."
30452920	ATF4	CAMP	"Yes, the explicit relationship described in the context between ""ATF4"" and ""CAMP"" is that ATF4 deficiency leads to reduced levels of CAMP, which is an antimicrobial peptide."
30452920	ATF4	LYZ1	"No, to answer this question, we need to find a direct relationship between ATF4 and LYZ1 in the provided context. While LYZ1 (Lysozyme C) is mentioned as a type of antimicrobial peptide whose levels are reduced in Atf4&#x394;IEC mice, the text does not explicitly establish a direct regulatory or functional relationship between ATF4 (activating transcription factor 4) and LYZ1."
30452920	ATF4	SLC1A5	Yes (SLC1A5 is explicitly mentioned as being directly regulated by ATF4 in cell lines.)
30452920	DEFA1	DEFA4	"No, the given context does not provide an explicit relationship between ""DEFA1"" and ""DEFA4"". While these genes are discussed along with other genes related to antimicrobial peptides, their specific relationship is not mentioned or described in this context."
30452920	DEFA1	DEFA5	"No, there is no explicit direct relationship described between ""DEFA1"" and ""DEFA5"" in this context. Both genes are mentioned as examples of antimicrobial peptides, but there is no specific connection between them."
30452920	DEFA1	CAMP	"Yes, to answer this question, I focused on the relationship between ""DEFA1"" and ""CAMP,"" which are two antimicrobial peptides mentioned in the given context. From the provided text, we can understand that Atf4-deficient mice had decreased levels of both DEFA1 and CAMP in ileal Paneth cells. DEFA1 injections reduced the severity of spontaneous enteritis and DSS-induced colitis in Atf4&#x394;IEC mice. Since ""CAMP"" is also among the antimicrobial peptides affected in this situation, we can infer an implicit relationship between DEFA1 and CAMP, as both of them are affected in Atf4-deficient mice and in response to DEFA1 injections. So, my answer is: yes."
30452920	DEFA1	LYZ1	"No, the given context doesn't explicitly describe a direct relationship between DEFA1 and LYZ1. Both are mentioned as part of the decreased antimicrobial peptides in Atf4&#x394;IEC mice, but no specific relationship or regulation between DEFA1 and LYZ1 is established."
30452920	DEFA1	SLC1A5	"No, the explicit relationship between ""DEFA1"" and ""SLC1A5"" is that expression of ""SLC1A5"" (a glutamine transporter) is directly regulated by ""ATF4"" in cell lines, and overexpression of ""SLC1A5"" increased glutamine uptake and expression of antimicrobial peptides like ""DEFA1""."
30452920	DEFA4	DEFA5	"No, DEFA4 and DEFA5 are mentioned as antimicrobial peptides, and their reduced levels are seen in Atf4-deficient mice, but there is no explicit relationship described between DEFA4 and DEFA5 in this given context."
30452920	DEFA4	CAMP	"No, based on the given context, there is no direct explicit relationship mentioned between ""DEFA4"" and ""CAMP"" except that both are described as reduced levels of antimicrobial peptides in Atf4-deficient mice."
30452920	DEFA4	LYZ1	"No, there is no explicit relationship mentioned between ""DEFA4"" and ""LYZ1"" in this context. Both are mentioned as antimicrobial peptides that were reduced in Atf4-deficient mice, but there is no direct relationship between them described within the text."
30452920	DEFA4	SLC1A5	"No, DEFA4 and SLC1A5 are not explicitly described to have a direct relationship in this given context. DEFA4 refers to antimicrobial peptides found in Paneth cells that are reduced in Atf4-deficient mice, while SLC1A5 is a glutamine transporter regulated by ATF4 in cell lines, contributing to the glutamine uptake and expression of antimicrobial peptides in intestinal epithelial cells."
30452920	DEFA5	CAMP	"No, the explicit relationship between ""DEFA5"" and ""CAMP"" in the given context is that both of them are reduced antimicrobial peptides in ileal Paneth cells of Atf4-deficient mice. There is no direct relationship established between DEFA5 and CAMP beyond the fact that they share a similar feature."
30452920	DEFA5	LYZ1	"No, there is no explicit direct relationship mentioned between ""DEFA5"" and ""LYZ1"" in this context. Both proteins are mentioned as decreased antimicrobial peptides in Atf4-deficient mice, but there's no explicit mentioned relationship between the two."
30452920	DEFA5	SLC1A5	"No, ""SLC1A5"" is the explicit relationship in the text related to the process or gene function involving ""glutamine uptake"" in the context given, whereas there is no explicit connection between ""DEFA5"" and ""SLC1A5"". DEFA5 is mentioned as one of the antimicrobial peptides whose expression is influenced by ATF4."
30452920	CAMP	LYZ1	"No, ""CAMP"" and ""LYZ1"" are not explicitly related in this context, although both are mentioned as antimicrobial peptides that were found to have their levels reduced in Atf4&#x394;IEC mice. There is an explicit relationship between ATF4 and the expression of these antimicrobial peptides, including CAMP and LYZ1."
30452920	CAMP	SLC1A5	"No, there is no explicit direct relationship described between ""CAMP"" and ""SLC1A5"" in the given context. ATF4 is described to have a relationship with both: a decrease in ATF4 leads to reduced antimicrobial peptide expression including CAMP and SLC1A5 decreased expression is a result of ATF4 knockdown which in turn affects glutamine uptake in cells."
30452920	LYZ1	SLC1A5	"No, there is no direct explicit relationship mentioned between ""LYZ1"" and ""SLC1A5"" in this context. LYZ1 (Lysozyme C, also known as CAMP) is discussed as an antimicrobial peptide, whereas SLC1A5 is a glutamine transporter directly regulated by ATF4."
15307176	CD46	IL-12	"Yes, there is a relationship between ""CD46"" and the context of IL-12, as it is mentioned that the enhancement of cytokine secretion such as IL-2 and IFN-gamma by coligation of CD3 and CD46 does not require IL-12. This suggests that CD46 costimulation promotes a Th1-biased response independently of IL-12 in human CD4+ T lymphocytes."
15309723	PDGF	Fas	"Yes (The relationship between PDGF and Fas is indirect through its effect on the expression of Bcl-2/Bax mRNA levels, while the relationship between IL-10 and Fas/FasL is direct  it increases FasL expression, leading to potential effects on HSC apoptosis.)"